_id,from_id,to_id,properties
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42281,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:0,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7161,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Glioblastoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42282,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:5,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Pain in extremity"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42283,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:6,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7186,"{""doseUnit"": ""IU"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1600"", ""indication"": ""Lipidosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42284,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42285,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""59"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42287,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:14,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:15,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42289,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:16,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42290,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:16,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42291,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:17,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""4.5"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42292,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:19,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42293,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:20,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42294,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:22,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42295,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:22,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42296,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:23,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42297,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:24,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.9"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42298,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:25,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42299,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:25,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:27,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42301,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:29,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:30,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42303,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:30,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42304,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:34,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Neuralgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42305,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:35,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42306,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:36,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""68"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42307,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:36,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42308,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:37,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""900"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42309,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:37,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""28"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42310,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:38,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7179,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1.19"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42311,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:39,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7224,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""90"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:41,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""1.5"", ""indication"": ""Cataplexy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""1.25"", ""indication"": ""Somnolence"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42314,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:47,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42316,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:48,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7235,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1.25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:49,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42318,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:50,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""4.5"", ""indication"": ""Narcolepsy"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42319,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:51,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42320,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:51,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42321,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:51,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1650"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42322,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:51,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42323,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:52,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42324,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:52,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7245,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.4"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42325,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:52,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""125"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42326,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:52,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG/M**2"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42327,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:52,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:54,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7249,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""240"", ""indication"": ""Multiple sclerosis"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42329,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:56,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42330,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:57,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42331,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:58,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""3.8"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42332,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:60,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.5"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42333,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:61,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42334,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:61,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""60"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42335,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:62,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42336,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:62,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7277,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42337,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:64,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42338,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:66,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42339,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:68,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42340,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:69,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42341,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:70,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42342,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:70,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42343,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:72,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42344,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:72,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42345,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:75,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42346,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:75,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42347,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:76,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42348,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:76,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42349,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:79,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42350,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:79,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42351,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:79,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7302,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42352,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:81,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Neuralgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42353,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:82,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42354,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:83,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42355,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:84,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.5"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42356,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:84,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42357,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:84,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7304,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42358,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:85,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42359,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:85,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""12"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42360,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:86,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42361,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:86,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42362,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:87,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42363,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:87,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42364,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:89,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42365,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:89,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42366,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:90,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7305,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42367,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:103,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7233,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""End stage renal disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42368,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:114,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42369,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:114,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42370,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:115,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42371,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:115,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42372,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:116,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42373,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:116,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Unknown"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:118,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42375,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:120,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42376,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:122,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42377,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:122,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42378,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:123,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7288,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.25"", ""indication"": ""Non-alcoholic steatohepatitis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42379,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:123,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7316,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""15"", ""indication"": ""Diabetes mellitus management"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42380,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:123,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7317,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""160"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42381,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:123,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7318,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""875"", ""indication"": ""Pharyngitis streptococcal"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42382,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:125,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42383,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:126,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7288,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5"", ""indication"": ""Partial lipodystrophy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42384,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:127,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42385,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:127,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""ML"", ""route"": ""Intratracheal "", ""doseAmount"": ""5"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42386,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:127,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intratracheal "", ""doseAmount"": ""100"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42387,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:145,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42388,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:147,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42389,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:148,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42390,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:149,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42391,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:149,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7172,"{""doseUnit"": ""UG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1560"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:150,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42393,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:151,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:151,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42395,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:155,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7351,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42396,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:156,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.96"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42397,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:156,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""32"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:158,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42399,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:158,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7250,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""190"", ""indication"": ""Stem cell transplant"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42400,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:158,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42401,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:159,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42402,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:160,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""58"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:160,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42404,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:161,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42405,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42406,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42407,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""98"", ""indication"": ""Chemotherapy"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42408,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42409,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Chemotherapy"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42410,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1310"", ""indication"": ""Chemotherapy"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42411,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7355,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3330"", ""indication"": ""Chemotherapy"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42412,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:166,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7357,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42413,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42414,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:168,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7359,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""500"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42415,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:169,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:170,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42417,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:171,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7360,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:171,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42419,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:173,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42420,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:174,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:175,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""28"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:175,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""27"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42423,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:176,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42424,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:179,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42425,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:180,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Pain in extremity"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42426,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:181,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7380,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42427,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:181,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42428,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:182,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42429,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:182,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42430,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:183,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42431,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:184,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42432,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:184,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7360,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42433,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:185,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42434,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:186,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42435,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:187,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7384,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42436,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:188,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Fibromyalgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:189,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7394,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""17"", ""indication"": ""Parkinson's disease psychosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42438,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:190,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7402,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""90"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42439,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:190,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42440,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:191,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42441,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:191,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42442,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:191,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42443,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:192,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Connective tissue disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:193,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42445,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:194,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7415,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:195,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42447,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:195,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""900"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42448,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:196,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Fallopian tube cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42449,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:197,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""36"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42450,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:197,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42451,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:199,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7432,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""500"", ""indication"": ""Pancreas transplant"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42452,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:199,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7321,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""500"", ""indication"": ""Renal transplant"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42453,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:200,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42454,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:200,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7360,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42455,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:201,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42456,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:201,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7435,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42457,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:202,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42458,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:203,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42459,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:204,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7218,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Hypertonic bladder"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42460,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:204,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7436,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Hypertonic bladder"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42461,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:205,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42462,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:206,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7437,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""45"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42463,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:207,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42464,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:208,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42465,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:209,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.06"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42466,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:209,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7439,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Heritable pulmonary arterial hypertension"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42467,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:210,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42468,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:210,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42469,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:210,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7302,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42470,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:211,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""56"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42471,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:211,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""500"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42472,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:211,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42473,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:212,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42474,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:213,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7394,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""34"", ""indication"": ""Parkinson's disease psychosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42475,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:214,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7442,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""594"", ""indication"": ""Squamous cell carcinoma of head and neck"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42476,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:214,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""124"", ""indication"": ""Squamous cell carcinoma of head and neck"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42477,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:214,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7445,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5"", ""indication"": ""Light anaesthesia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42478,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:215,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""3.75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:216,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42480,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:216,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42481,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""56"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42482,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42483,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:218,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7446,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""70"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42484,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:218,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7165,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Hypertension"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42485,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:219,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7451,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""32"", ""indication"": ""Plasma cell myeloma recurrent"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42486,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:219,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma recurrent"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42487,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:220,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7452,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""8.4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42488,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:221,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""4.5"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42489,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:223,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42490,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:223,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:225,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7291,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42492,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:231,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42493,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:232,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7468,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""350"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42494,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:232,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42495,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:234,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42496,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:234,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42497,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:234,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42498,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:235,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7473,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1850"", ""indication"": ""Neoplasm"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42499,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:236,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""4.5"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42500,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:238,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42501,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:239,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.1"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42502,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:239,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""12"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42503,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:241,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7478,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""37.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42504,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:242,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7360,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42505,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:242,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42506,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:243,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Fibromyalgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42507,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:245,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42508,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:246,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42509,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:250,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42510,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:250,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42511,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:251,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42512,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:251,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42513,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:252,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42514,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:253,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7206,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42515,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:254,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42516,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:255,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7502,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42517,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:257,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7451,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42518,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:257,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""21.5"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42519,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:259,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42520,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:261,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7248,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42521,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:261,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7524,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""12"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42522,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:261,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7525,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""12"", ""indication"": ""Multiple sclerosis"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42523,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:262,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42524,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:263,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7526,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""500"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42525,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:264,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42526,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:265,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42527,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:265,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42528,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:266,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.269"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42529,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:269,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42530,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:271,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7530,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42531,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:272,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Pain"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42532,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:282,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42533,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:282,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42534,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:283,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""70"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42535,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:283,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42536,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:284,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42537,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:284,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42538,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""826.5"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42539,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""271"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42540,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7539,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""385"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42541,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42542,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7360,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42543,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:289,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42544,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:290,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42545,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:293,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7406,"{""doseUnit"": ""DF"", ""route"": ""Transplacental"", ""doseAmount"": ""1"", ""indication"": ""Pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42546,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:293,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7542,"{""doseUnit"": ""MG"", ""route"": ""Transplacental"", ""doseAmount"": ""8"", ""indication"": ""Pain"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42547,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:293,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7543,"{""doseUnit"": ""MG"", ""route"": ""Transplacental"", ""doseAmount"": ""8"", ""indication"": ""Pain"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42548,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:293,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7544,"{""doseUnit"": ""MG"", ""route"": ""Transplacental"", ""doseAmount"": ""8"", ""indication"": ""Pain"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42549,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:296,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42550,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:296,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42551,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:296,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7546,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42552,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:296,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7203,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42553,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:296,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:296,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42555,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:297,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7495,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42556,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:297,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42557,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:297,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7203,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42558,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:298,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42559,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:298,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42560,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42561,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42562,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42563,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7553,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""60"", ""indication"": ""Unknown"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42564,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42565,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:301,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42566,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:301,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Barrett's oesophagus"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:301,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42568,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:301,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7203,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Barrett's oesophagus"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42569,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:301,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Barrett's oesophagus"", ""drugSequence"": ""16""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42570,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42571,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7546,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42572,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7553,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""60"", ""indication"": ""Unknown"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7203,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42574,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7561,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42575,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7562,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42576,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42577,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7563,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""16""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42578,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:303,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrointestinal disorder"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42579,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:303,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42580,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:303,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7562,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42581,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:306,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42582,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:306,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42583,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:307,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42584,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:307,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42585,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:307,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42586,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:307,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""18""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42587,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:308,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42588,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:308,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7546,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42589,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:308,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42590,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:309,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Prophylaxis"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42591,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:309,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42592,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:310,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42593,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:310,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7203,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42594,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:310,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42595,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:311,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7495,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42596,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:311,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42597,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:311,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42598,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:311,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7571,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42599,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7495,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""15"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42600,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42601,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7546,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42602,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7571,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""15"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42603,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7203,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42604,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42605,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7366,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""17""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42606,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""18""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42607,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42608,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7495,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42609,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42610,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42611,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42612,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42613,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42614,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:316,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42615,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:316,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7495,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42616,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:316,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Flatulence"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42617,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7561,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42618,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7546,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42619,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42620,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42621,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42622,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:318,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7546,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42623,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:318,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7571,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42624,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:318,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42625,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:320,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7162,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42626,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:320,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7612,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.5"", ""indication"": ""Anxiety"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42627,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:321,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""240"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42628,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:323,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7495,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42629,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:323,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7626,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Product use in unapproved indication"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42630,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:323,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Product use in unapproved indication"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42631,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:324,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42632,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:326,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42633,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:326,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1660"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42634,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:327,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""56"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42635,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:327,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42636,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7495,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42637,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42638,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42639,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7546,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42640,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42641,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:329,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1"", ""indication"": ""Nausea"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42642,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:331,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7251,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""58"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42643,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:331,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7451,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42644,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:332,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7634,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""180"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42645,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:332,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7635,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""180"", ""indication"": ""HER2 positive breast cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42646,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:332,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7636,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""180"", ""indication"": ""HER2 positive breast cancer"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42647,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:333,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42648,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:334,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42649,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:335,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42650,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:335,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7645,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42651,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:336,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7414,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""80"", ""indication"": ""Dyslipidaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42652,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:337,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""3.75"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42653,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:338,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7206,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42654,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:338,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1600"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42655,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:338,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.1"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42656,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:339,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7286,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42657,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:339,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7561,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42658,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:339,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7546,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42659,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:339,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42660,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:339,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7645,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42661,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:341,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1600"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42662,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:341,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7451,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42663,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:341,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.1"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42664,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:342,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42665,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:344,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7394,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""17"", ""indication"": ""Hallucination"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42666,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:346,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42667,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:348,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7502,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:349,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42669,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:349,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7402,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""90"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42670,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:350,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7681,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""14"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42671,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:351,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7682,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""75"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42672,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:351,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42673,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:352,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""3.5"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42674,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:353,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7683,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42675,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:353,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42676,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:354,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42677,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:355,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42678,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:357,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""11"", ""indication"": ""Rheumatoid arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42679,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:359,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""145"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42680,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:360,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7687,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Pituitary tumour benign"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42681,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:361,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42682,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:361,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7251,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42683,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:361,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42684,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:363,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7218,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42685,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:366,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Fibromyalgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42686,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:367,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42687,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:368,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42688,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:369,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.214"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42689,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:370,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42690,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:370,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""56"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42691,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:371,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7699,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""990"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42692,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:372,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7702,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""500"", ""indication"": ""Breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42693,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:373,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7468,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""500"", ""indication"": ""Breast cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42694,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:373,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Breast cancer metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42695,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7468,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""780"", ""indication"": ""Breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42696,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""80"", ""indication"": ""Breast cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42697,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:375,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7539,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""942"", ""indication"": ""Breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42698,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:375,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7684,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""318"", ""indication"": ""Breast cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42699,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:376,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7468,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1200"", ""indication"": ""Breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42700,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:381,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:382,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7702,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42702,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:382,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7684,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Breast cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42703,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:386,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7719,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42704,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:388,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""120"", ""indication"": ""Squamous cell carcinoma of head and neck"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42705,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:388,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7262,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Pain"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42706,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:390,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Unknown"", ""doseAmount"": ""0.331"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42707,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:391,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42708,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:393,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42709,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:393,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""2090"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42710,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42711,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42712,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42713,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:395,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42714,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:396,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""160"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42715,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:397,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7733,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42716,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7734,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""131"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42717,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7735,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""131"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42718,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7736,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""131"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42719,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7737,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""131"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42720,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7738,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""131"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42721,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""131"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42722,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:399,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.31"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42723,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:401,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7468,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42724,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:401,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42725,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:402,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42726,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7384,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42727,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:405,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7687,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Acromegaly"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42728,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:406,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7495,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42729,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:406,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7571,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42730,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:406,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7561,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42731,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:406,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42732,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:406,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""18""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42733,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:407,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Fibromyalgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42734,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:408,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7160,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Seizure"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42735,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:409,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42736,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42737,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42738,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42739,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""2700"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42740,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42741,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42742,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42743,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7302,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42744,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""2100"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42745,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""UG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Unknown"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42746,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:419,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7760,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1500"", ""indication"": ""Colon cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42747,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42748,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""27"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42749,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42750,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42751,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7451,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42752,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42753,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42754,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""2000"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42755,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:423,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7764,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42756,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:427,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42757,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:428,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42758,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:428,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7683,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42759,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:429,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42760,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:429,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7451,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42761,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:429,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""56"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42762,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:431,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Neuralgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42763,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:433,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:435,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""197"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42765,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42766,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:440,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""56"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42767,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:441,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""175"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42768,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:441,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7539,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""605"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42769,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:442,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7360,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42770,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:442,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42771,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1304"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42772,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""343"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7539,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""827.7"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42774,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7788,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""28.6"", ""indication"": ""Unknown"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42775,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1840"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42776,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""90"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42777,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""19""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42778,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7789,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""120"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""21""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42779,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:447,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42780,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:447,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42781,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:448,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""22"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42782,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:449,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42783,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:450,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42784,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:451,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""252"", ""indication"": ""Ovarian cancer stage III"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42785,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:451,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7539,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""510"", ""indication"": ""Ovarian cancer stage III"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42786,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:454,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42787,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:456,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42788,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:456,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42789,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:458,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3.1"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42790,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:459,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:460,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7766,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42792,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:461,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7807,"{""doseUnit"": ""UG"", ""route"": ""Intramuscular"", ""doseAmount"": ""240"", ""indication"": ""Immunisation"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42793,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:461,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7516,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42794,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:462,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42795,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:467,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42796,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:468,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7808,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""37.75"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42797,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:469,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42798,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:470,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7818,"{""doseUnit"": ""MG"", ""route"": ""Other"", ""doseAmount"": ""0.3"", ""indication"": ""Macular degeneration"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42799,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:471,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7687,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:473,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Pain in extremity"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42801,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:474,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42802,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:476,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42803,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:478,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Neuralgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42804,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42805,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7546,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42806,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7366,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrointestinal disorder"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42807,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42808,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7571,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""15"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42809,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7203,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42810,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42811,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7821,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42812,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42813,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:480,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42814,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:481,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Pain in extremity"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42815,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:482,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Lumbar radiculopathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42816,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:483,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42817,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:483,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42818,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:484,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42819,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:486,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42820,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:488,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42821,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:488,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7835,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""800"", ""indication"": ""Neuralgia"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42822,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7352,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42823,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.38"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7643,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""8600"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42825,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""90"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42826,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42827,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1840"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42828,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7788,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""28.6"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""17""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42829,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7838,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""120"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""18""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42830,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7355,"{""doseUnit"": ""IU"", ""route"": ""Unknown"", ""doseAmount"": ""4598"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""20""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42831,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:492,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.7"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42832,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:492,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42833,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:493,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7268,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""80"", ""indication"": ""Stent placement"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42834,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:496,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7502,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Cholangiocarcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42835,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:499,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7850,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""180"", ""indication"": ""Anaplastic lymphoma kinase gene mutation"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42836,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:502,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7478,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""37.5"", ""indication"": ""Metastatic gastric cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42837,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:503,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7851,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42838,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:507,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7437,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42839,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:508,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1.6"", ""indication"": ""Bone disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42840,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:509,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42841,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:511,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""36"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42842,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:512,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7853,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42843,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:513,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42844,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:514,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7235,"{""doseUnit"": ""G"", ""route"": ""Vaginal"", ""doseAmount"": ""1"", ""indication"": ""Vulvovaginal dryness"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42845,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:517,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42846,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:520,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42847,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:521,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Fibromyalgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42848,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:525,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42849,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:525,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42850,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:527,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42851,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:528,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Testicular pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42852,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:530,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7860,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""14"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42853,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:530,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""200"", ""indication"": ""Neoplasm"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:531,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42855,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:531,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42856,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:532,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42857,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:534,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7863,"{""doseUnit"": ""MG"", ""route"": ""Transdermal"", ""doseAmount"": ""0.037"", ""indication"": ""Menopause"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42858,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:535,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42859,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:536,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42860,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:537,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42861,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:539,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7874,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2235"", ""indication"": ""Factor VIII deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42862,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:540,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42863,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:541,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42864,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:541,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42865,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:542,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42866,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:543,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:543,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42868,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:549,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:549,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42870,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:549,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42871,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:550,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7235,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42872,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:552,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7851,"{""doseUnit"": ""MG"", ""route"": ""Topical"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42873,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:553,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42874,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:553,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42875,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7876,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1312"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42876,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7877,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42877,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42878,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7878,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42879,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:555,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:555,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7719,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42881,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:555,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7882,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42882,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:556,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""175"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42883,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:558,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7884,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42884,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:560,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42885,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:560,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7251,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""70"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42886,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:561,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7887,"{""doseUnit"": ""UG"", ""route"": ""Intramuscular"", ""doseAmount"": ""240"", ""indication"": ""Immunisation"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42887,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:562,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Cystic fibrosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:563,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""12"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:564,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7553,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""60"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42890,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:565,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7359,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42891,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:566,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42892,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:566,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42893,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:566,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrointestinal disorder"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42894,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:566,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""16""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42895,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:566,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""20""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42896,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42897,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42898,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42899,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42900,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""3100"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""18""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42901,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7250,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""153"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""20""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42902,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7251,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""22""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42903,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7302,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""23""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42904,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7360,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""25""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42905,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""27""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42906,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7892,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""7.5"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""29""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42907,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""12"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""30""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42908,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""310"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""31""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42909,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:571,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7893,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""250"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42910,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:572,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""175"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42911,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7233,"{""doseUnit"": ""UG"", ""route"": ""Intravenous bolus"", ""doseAmount"": ""225"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42912,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:575,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42913,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:575,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7683,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42914,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:576,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:576,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42916,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:576,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42917,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:577,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""135"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42918,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:578,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42919,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:578,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""27"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42920,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:579,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42921,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:579,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7451,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42922,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:580,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7897,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""84"", ""indication"": ""On and off phenomenon"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42923,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:581,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42924,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:581,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42925,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:582,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Type 2 diabetes mellitus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42926,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:583,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7451,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42927,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:583,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:584,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42929,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:584,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42930,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:585,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42931,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:586,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""175"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42932,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:586,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""15"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42933,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:587,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""125"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42934,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:587,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42935,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:587,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42936,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:587,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7245,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.4"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42937,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:587,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG/M**2"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42938,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:590,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42939,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:596,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42940,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:596,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1180"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42941,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:597,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42942,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:597,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""900"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42943,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:598,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7902,"{""doseUnit"": ""MG/KG"", ""route"": ""Unknown"", ""doseAmount"": ""35"", ""indication"": ""Haemophagocytic lymphohistiocytosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42944,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:598,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7903,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""25"", ""indication"": ""Juvenile idiopathic arthritis"", ""drugSequence"": ""19""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42945,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:598,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7904,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Haemophagocytic lymphohistiocytosis"", ""drugSequence"": ""20""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42946,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:598,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7905,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""240"", ""indication"": ""Haemophagocytic lymphohistiocytosis"", ""drugSequence"": ""28""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42947,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:599,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42948,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:601,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7913,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42949,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:603,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7914,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42950,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:604,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7918,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42951,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:608,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42952,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:608,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42953,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:619,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7702,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""140"", ""indication"": ""Breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42954,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:619,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7684,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""140"", ""indication"": ""Breast cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42955,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:622,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7688,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""120"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42956,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:624,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42957,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:625,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Neuritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42958,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:628,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7931,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""160"", ""indication"": ""Hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42959,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:629,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""960"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42960,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:629,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7451,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42961,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:631,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""15"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42962,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:631,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""175"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42963,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:632,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42964,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:633,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""4.35"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42965,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:634,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42966,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:635,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42967,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:636,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42968,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:636,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42969,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:637,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42970,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:637,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42971,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:637,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42972,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:638,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42973,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:640,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:642,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""758"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42975,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:642,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""101"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42976,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:642,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1516"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42977,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:642,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42978,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:646,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""205"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42979,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:646,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7950,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""122.5"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42980,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:647,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""400"", ""indication"": ""Migraine"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42981,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:648,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""110"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42982,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:650,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7442,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""800"", ""indication"": ""Neoplasm"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42983,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:651,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42984,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:651,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7360,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42985,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:653,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7748,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42986,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:653,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Neuralgia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42987,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:653,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7618,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""800"", ""indication"": ""Pain"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42988,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:654,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1200"", ""indication"": ""Metastatic neoplasm"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42989,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:655,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7862,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Dermatitis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42990,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:656,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7961,"{""doseUnit"": ""UG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""25"", ""indication"": ""Post procedural hypoparathyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42991,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:657,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42992,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:658,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42993,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:659,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Type 2 diabetes mellitus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42994,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:660,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42995,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:661,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42996,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:662,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""180"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42997,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:665,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""3.18"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42998,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:665,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:42999,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:665,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43000,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:665,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7876,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1800"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43001,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:667,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43002,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""3.1"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43003,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7876,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1800"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43004,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43005,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43006,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:671,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7961,"{""doseUnit"": ""UG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""50"", ""indication"": ""Post procedural hypoparathyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43007,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:672,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Osteoarthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43008,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:673,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7502,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""780"", ""indication"": ""Cholangiocarcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43009,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:674,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7950,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""150"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43010,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:675,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""750"", ""indication"": ""Peripheral T-cell lymphoma unspecified"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43011,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:675,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7976,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.8"", ""indication"": ""Peripheral T-cell lymphoma unspecified"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43012,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:675,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Peripheral T-cell lymphoma unspecified"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43013,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:675,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Peripheral T-cell lymphoma unspecified"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:676,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""800"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43015,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:676,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""298"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43016,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:676,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43017,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:676,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1610"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43018,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:676,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7352,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.7"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43019,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:676,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7977,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43020,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:682,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""375"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43021,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:682,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7473,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43022,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:682,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43023,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:684,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7359,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43024,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:685,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""160"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43025,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:686,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43026,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:688,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7179,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""45"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43027,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:690,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43028,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:690,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7920,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43029,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:692,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7321,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""250"", ""indication"": ""Renal transplant"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43030,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:693,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7984,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43031,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:694,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43032,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:695,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7991,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""9900"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43033,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:695,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7539,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""750"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43034,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:695,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43035,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:697,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43036,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:698,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43037,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:699,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43038,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:699,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7468,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43039,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:699,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7992,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43040,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:700,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43041,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7451,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43042,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""150"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43043,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7199,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43044,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43045,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""35"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43046,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:702,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43047,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:702,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43048,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:703,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43049,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:704,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Primary immunodeficiency syndrome"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43050,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:705,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43051,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:706,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""7"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43052,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:707,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43053,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:708,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43054,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:709,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""7"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43055,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:711,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43056,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:712,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""140"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43057,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:714,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma refractory"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43058,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:714,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7252,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma refractory"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43059,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:714,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma refractory"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43060,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:716,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8004,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""84"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43061,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:718,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43062,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:720,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8005,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""360"", ""indication"": ""Metastatic malignant melanoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43063,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:721,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7782,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Cerebrovascular accident prophylaxis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43064,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:721,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8011,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43065,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:722,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43066,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:725,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43067,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:726,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7918,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43068,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:727,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8011,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43069,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:727,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""186"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43070,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:727,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7950,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""114"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43071,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:727,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7270,"{""doseUnit"": ""MG"", ""route"": ""Intravenous bolus"", ""doseAmount"": ""8"", ""indication"": ""Nausea"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43072,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:728,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43073,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:729,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""140"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43074,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:730,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7734,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43075,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:733,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""45"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43076,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:735,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43077,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:735,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43078,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:736,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43079,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:737,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43080,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:739,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""16"", ""indication"": ""Illness"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43081,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:741,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7961,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Hypoparathyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43082,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:742,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Fibromyalgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43083,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:743,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""120"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43084,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:744,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""140"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43085,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:745,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43086,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:749,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43087,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:750,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43088,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:751,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7897,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""84"", ""indication"": ""On and off phenomenon"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43089,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:751,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8034,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""274"", ""indication"": ""Dyskinesia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43090,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:752,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43091,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:753,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43092,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:755,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7961,"{""doseUnit"": ""UG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""75"", ""indication"": ""Hypocalcaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43093,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:756,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8039,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""28"", ""indication"": ""Peripheral T-cell lymphoma unspecified refractory"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43094,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:760,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43095,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:761,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43096,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:762,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8040,"{""doseUnit"": ""UG"", ""route"": ""Intramuscular"", ""doseAmount"": ""30"", ""indication"": ""Multiple sclerosis"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43097,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:763,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43098,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:763,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8042,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""35"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43099,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""35"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43100,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43101,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8048,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.14"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43102,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8049,"{""doseUnit"": ""IU"", ""route"": ""Intramuscular"", ""doseAmount"": ""19000"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43103,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""12"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""17""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43104,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""57"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""22""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43105,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8050,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""45"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""24""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43106,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:765,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""280"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43107,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:767,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43108,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:769,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43109,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:770,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43110,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:770,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8053,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Transitional cell carcinoma"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:772,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43112,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7352,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.14"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43113,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""57"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43114,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7643,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""12"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43115,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""35"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43116,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8057,"{""doseUnit"": ""IU"", ""route"": ""Intramuscular"", ""doseAmount"": ""19000"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43117,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""760"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43118,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7838,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""45"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""16""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43119,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""17""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43120,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:774,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8058,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43121,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:775,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43122,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:776,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7876,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43123,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:777,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43124,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:779,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43125,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:779,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7882,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""3"", ""indication"": ""Hereditary angioedema"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43126,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:781,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8058,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""4328"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43127,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:784,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Other"", ""doseAmount"": ""0.42"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43128,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:787,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7874,"{""doseUnit"": ""IU"", ""route"": ""Intravenous drip"", ""doseAmount"": ""2500"", ""indication"": ""Factor VIII deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43129,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:789,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43130,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:790,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7827,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43131,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8063,"{""doseUnit"": ""UG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43132,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:792,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43133,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:793,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43134,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:794,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8066,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43135,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:794,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7473,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1920"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43136,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:794,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8067,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""240"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43137,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:795,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43138,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:796,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8069,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43139,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:797,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8069,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43140,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:798,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8069,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43141,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:799,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43142,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""57"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43143,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8072,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""12"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43144,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""35"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43145,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.14"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43146,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8057,"{""doseUnit"": ""IU"", ""route"": ""Intramuscular"", ""doseAmount"": ""19000"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43147,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""760"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""16""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43148,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7789,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""45"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""17""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43149,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:801,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""180"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43150,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:801,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7950,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""110"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43151,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:802,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43152,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:803,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""35"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43153,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:804,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43154,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:806,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43155,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:808,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43156,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:808,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1200"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43157,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:809,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8085,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.5"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43158,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:815,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""11"", ""indication"": ""Selective IgG subclass deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43159,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:817,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.09"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43160,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:818,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43161,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:820,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:821,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7893,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""250"", ""indication"": ""PIK3CA related overgrowth spectrum"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:822,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43164,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:823,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43165,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43166,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43168,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.9"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43169,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""500"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43170,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43171,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""45"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43172,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:825,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2.93"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43173,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:827,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43174,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:828,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""215"", ""indication"": ""Transitional cell cancer of renal pelvis and ureter metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43175,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:829,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7782,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43176,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:829,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8089,"{""doseUnit"": ""MG/M**2"", ""route"": ""Unknown"", ""doseAmount"": ""500"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43177,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:830,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43178,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:830,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43179,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:830,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7250,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""100"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43180,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:830,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7451,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43181,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:831,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Breast cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43182,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:832,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43183,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:833,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43184,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:834,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43185,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:835,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43186,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:836,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""B-lymphocyte abnormalities"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43187,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:837,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43188,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:838,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43189,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:839,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""25"", ""indication"": ""Primary immunodeficiency syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43190,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:840,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43191,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:842,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7196,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43192,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:843,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43193,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:845,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8092,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pain"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43194,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:847,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7783,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Hepatitis B"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43195,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:847,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8096,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""HIV infection"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43196,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:848,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""18"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43197,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:849,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""67.5"", ""indication"": ""Encephalitis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43198,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:851,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8097,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""90"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43199,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:853,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8099,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Hepatocellular carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43200,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Hereditary angioedema with C1 esterase inhibitor deficiency"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43201,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7719,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43202,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:855,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43203,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:855,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8100,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Crohn's disease"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43204,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:856,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7734,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""130"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43205,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:856,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7735,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""165"", ""indication"": ""Invasive ductal breast carcinoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43206,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:856,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7737,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""165"", ""indication"": ""Invasive ductal breast carcinoma"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43207,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:857,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43208,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:860,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7179,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""85"", ""indication"": ""Lipidosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43209,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:861,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8114,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43210,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:862,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43211,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:864,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8119,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43212,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:865,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43213,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:865,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43214,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:866,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43215,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:866,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7876,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43216,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43218,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43219,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43220,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43221,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43222,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""16""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43223,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""160"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43224,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7643,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""15"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43225,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43226,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2200"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43227,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7355,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5500"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43228,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:870,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8123,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""22.6"", ""indication"": ""Glycogen storage disease type II"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43229,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:871,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8124,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43230,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:871,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8125,"{""doseUnit"": ""MG/M**2"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43231,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:871,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG/M**2"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43232,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:871,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43233,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:871,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""35"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43234,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:871,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.19"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""24""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43235,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:872,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8126,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43236,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:874,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43237,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:875,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8132,"{""doseUnit"": ""MG"", ""route"": ""Intravenous bolus"", ""doseAmount"": ""56.6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43238,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:876,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43239,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""24"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43240,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:881,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.318"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43241,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:882,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43242,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:883,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8138,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43243,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:884,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8139,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""284"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43244,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:885,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8139,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""284"", ""indication"": ""Unknown"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43245,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:886,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8139,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""284"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43246,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""240"", ""indication"": ""Angiosarcoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43247,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43248,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""15"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43249,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43250,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2200"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43251,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43252,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7355,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5500"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43253,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:890,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43254,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:893,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Combined immunodeficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43255,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:894,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8151,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""640"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43256,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:896,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43257,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:897,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7467,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43258,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:897,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8153,"{""doseUnit"": ""UG"", ""route"": ""Intramuscular"", ""doseAmount"": ""450"", ""indication"": ""Dementia Alzheimer's type"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43259,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:898,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43260,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:899,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43261,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:901,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8058,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3387"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43262,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:902,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Monoclonal gammopathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43263,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:904,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43264,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:905,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43265,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:906,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7234,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.5"", ""indication"": ""Multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43266,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:907,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43267,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:908,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Selective IgG subclass deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43268,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:909,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43269,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:910,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43270,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:911,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Back pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43271,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:912,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""33"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43272,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:913,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43273,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:914,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7961,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Hypoparathyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43274,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.39"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43275,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:916,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Crohn's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43276,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:917,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8168,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""HIV infection"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43277,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:917,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8169,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""HIV infection"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43278,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:920,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43279,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:921,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Immunodeficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43280,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:922,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8174,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43281,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:923,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43282,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:924,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43283,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:925,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""172"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43284,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:926,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""4.5"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43285,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:927,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8182,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7495,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43287,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8182,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43289,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8183,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43290,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7562,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43291,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43292,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43293,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7546,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43294,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7203,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43295,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7553,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43296,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:930,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43297,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:931,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43298,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:931,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43299,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:931,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:932,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43301,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:933,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:934,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43303,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:934,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8185,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""294"", ""indication"": ""Bladder cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43304,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:935,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Other"", ""doseAmount"": ""2.74"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43305,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:937,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43306,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:938,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43307,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:939,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Hormone-refractory prostate cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43308,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:940,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.54"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43309,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:950,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7384,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43310,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:950,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""550"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43311,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:950,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""182"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:951,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""14"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:952,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8099,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Hormone-refractory prostate cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43314,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:953,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8188,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""120"", ""indication"": ""Prostate cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:955,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8190,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""7.5"", ""indication"": ""Pain"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43316,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:955,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8191,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pain"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:955,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8192,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""7.5"", ""indication"": ""Pain"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43318,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:956,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8063,"{""doseUnit"": ""UG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""50"", ""indication"": ""Hypoparathyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43319,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:957,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""DF"", ""route"": ""Other"", ""doseAmount"": ""0.35"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43320,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:958,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8193,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43321,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:959,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8194,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43322,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:960,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8058,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43323,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:961,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43324,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:964,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8058,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43325,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:965,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Colitis ulcerative"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43326,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:966,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7300,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43327,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:966,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8202,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Prophylaxis"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:967,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8092,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""240"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43329,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:968,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Raynaud's phenomenon"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43330,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:970,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""4"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43331,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:972,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8139,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""284"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43332,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:973,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43333,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43334,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""500"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43335,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43336,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""504"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43337,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:975,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7901,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43338,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:976,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43339,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:977,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43340,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:979,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8209,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""24""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43341,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:981,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7356,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43342,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:982,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8210,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43343,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:983,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Selective IgG subclass deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43344,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:986,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43345,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:987,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""280"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43346,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:988,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5"", ""indication"": ""Transient hypogammaglobulinaemia of infancy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43347,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:990,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43348,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:991,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8194,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43349,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:992,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7394,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""34"", ""indication"": ""Hallucination"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43350,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:993,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7394,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""34"", ""indication"": ""Hallucination"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43351,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:994,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43352,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:997,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43353,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:998,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG/M**2"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Triple positive breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43354,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:999,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8218,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Optic neuritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43355,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:999,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7905,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""180"", ""indication"": ""Rheumatoid arthritis"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43356,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1000,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3.6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43357,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1001,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8222,"{""doseUnit"": ""IU"", ""route"": ""Unknown"", ""doseAmount"": ""1000"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43358,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1001,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7882,"{""doseUnit"": ""ML"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43359,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1002,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43360,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1004,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7234,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.5"", ""indication"": ""Multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43361,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1005,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7860,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""14"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43362,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1005,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8223,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43363,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1005,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7295,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Hypertension"", ""drugSequence"": ""20""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43364,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1006,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7495,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43365,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1006,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7561,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43366,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1006,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43367,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1006,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7203,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43368,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1008,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""14"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43369,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1010,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43370,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1010,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7839,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Pain"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43371,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1011,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43372,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1012,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8123,"{""doseUnit"": ""ML"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""250"", ""indication"": ""Complement deficiency disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43373,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8224,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43375,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1015,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8118,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43376,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1016,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7356,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43377,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1016,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7181,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Blood pressure abnormal"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43378,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1017,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""DF"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43379,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1018,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7262,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""900"", ""indication"": ""Neuralgia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43380,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1019,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7437,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43381,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1021,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7734,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43382,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1023,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""38"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43383,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1024,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""35"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43384,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1028,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1.2"", ""indication"": ""Growth hormone deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43385,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1030,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""214.2"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43386,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1030,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1830"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43387,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1030,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""122"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43388,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1030,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43389,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1032,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7961,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Hypoparathyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43390,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1034,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7853,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43391,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1035,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""113"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1037,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43393,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1038,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7853,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1039,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""7"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43395,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1040,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43396,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1042,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43397,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1043,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8232,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""320"", ""indication"": ""Hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1043,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7931,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""320"", ""indication"": ""Hypertension"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43399,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1043,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7594,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""320"", ""indication"": ""Hypertension"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43400,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1045,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43401,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1049,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43402,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1050,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""120"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1051,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8138,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43404,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1054,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""45"", ""indication"": ""Selective IgA immunodeficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43405,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1056,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Back pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43406,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1057,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7437,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43407,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1058,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""90"", ""indication"": ""Chronic sinusitis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43408,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1060,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""185"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43409,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1062,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8237,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Hormone receptor positive HER2 negative breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43410,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1063,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7905,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""162"", ""indication"": ""Giant cell arteritis"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43411,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1064,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7813,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Fungal infection"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43412,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1065,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8242,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""450"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43413,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1066,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7502,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43414,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1066,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""840"", ""indication"": ""Lung adenocarcinoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43415,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1067,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7901,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""90"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1068,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43417,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1069,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8218,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Polymyositis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1069,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7432,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1000"", ""indication"": ""Polymyositis"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43419,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1070,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8243,"{""doseUnit"": ""MG"", ""route"": ""Transdermal"", ""doseAmount"": ""50"", ""indication"": ""Neuralgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43420,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1074,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1076,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""65"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1081,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43423,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1081,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43424,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1081,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43425,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1081,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.9"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43426,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1083,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""9"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43427,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1084,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43428,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1085,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.8"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43429,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1086,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1"", ""indication"": ""Immune enhancement therapy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43430,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1086,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7448,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Premedication"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43431,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1086,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8255,"{""doseUnit"": ""ML"", ""route"": ""Intramuscular"", ""doseAmount"": ""0.5"", ""indication"": ""Immunisation"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43432,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1086,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8256,"{""doseUnit"": ""ML"", ""route"": ""Intramuscular"", ""doseAmount"": ""0.5"", ""indication"": ""Pneumococcal immunisation"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43433,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1087,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7218,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43434,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1089,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8005,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""160"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43435,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1091,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8156,"{""doseUnit"": ""UG"", ""route"": ""Intrathecal"", ""doseAmount"": ""439.86"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43436,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1092,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8156,"{""doseUnit"": ""UG"", ""route"": ""Intrathecal"", ""doseAmount"": ""235.26"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1093,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43438,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1094,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43439,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1095,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8058,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3788"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43440,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1097,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8069,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43441,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1098,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.325"", ""indication"": ""Diarrhoea"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43442,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1099,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7901,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""110"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43443,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1101,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1106,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""13"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43445,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1106,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7996,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""37.5"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1110,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43447,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8291,"{""doseUnit"": ""UG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""28"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43448,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1730"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43449,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""104"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43450,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8292,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""70"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43451,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5.5"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43452,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7352,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43453,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7977,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""48"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""17""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43454,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8293,"{""doseUnit"": ""IU"", ""route"": ""Unknown"", ""doseAmount"": ""4477.5"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""18""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43455,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""12"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""22""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43456,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8294,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""26.25"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""30""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43457,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1112,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43458,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1114,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43459,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1114,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43460,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1115,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8222,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""500"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43461,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1115,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7996,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43462,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1118,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Neoplasm"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43463,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1119,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Ovarian cancer recurrent"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43464,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1119,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8236,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Ovarian cancer recurrent"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43465,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1120,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""24"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43466,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1121,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7551,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43467,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1121,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7785,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43468,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1122,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43469,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1123,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8139,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""284"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43470,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1124,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8298,"{""doseUnit"": ""ML"", ""route"": ""INTRACAVITY"", ""doseAmount"": ""1"", ""indication"": ""Erectile dysfunction"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43471,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1126,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43472,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1127,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7853,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43473,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1132,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""35"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43474,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1133,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8285,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""550"", ""indication"": ""Hepato-lenticular degeneration"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43475,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1133,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8302,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""250"", ""indication"": ""Hepato-lenticular degeneration"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43476,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1134,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43477,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1137,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43478,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1139,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7961,"{""doseUnit"": ""UG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""100"", ""indication"": ""Hypoparathyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1145,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Infection"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43480,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1146,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1200"", ""indication"": ""Transitional cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43481,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1146,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8317,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.25"", ""indication"": ""Transitional cell carcinoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43482,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1147,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Hormone-refractory prostate cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43483,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1148,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""45"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43484,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1149,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8321,"{""doseUnit"": ""IU"", ""route"": ""Subcutaneous"", ""doseAmount"": ""6000"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43485,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1150,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43486,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1151,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.3"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43487,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1153,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8323,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43488,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1155,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43489,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1156,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43490,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1158,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1160,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.7"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43492,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43493,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43494,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7468,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43495,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7190,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43496,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7250,"{""doseUnit"": ""MG/M**2"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43497,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43498,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7189,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""43"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43499,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43500,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43501,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""375"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43502,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8185,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""750"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43503,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""75"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43504,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1164,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""14"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43505,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1165,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.36"", ""indication"": ""Illness"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43506,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8190,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""7.5"", ""indication"": ""Pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43507,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8327,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Pain"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43508,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8328,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43509,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8329,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Pain"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43510,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8330,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Pain"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43511,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8277,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Pain"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43512,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7911,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43513,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7822,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43514,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7551,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43515,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7493,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43516,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7843,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43517,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7247,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""16""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43518,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7714,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""20""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43519,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1168,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""70"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43520,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1169,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Mesothelioma malignant"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43521,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1169,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""146"", ""indication"": ""Pleural mesothelioma malignant"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43522,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1169,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8089,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Pleural mesothelioma malignant"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43523,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1170,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43524,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1171,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8335,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43525,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1172,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43526,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1173,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43527,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1176,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7996,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""105"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43528,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1181,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""55"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43529,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1183,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8340,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43530,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1184,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8344,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""500"", ""indication"": ""Breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43531,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1185,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7394,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""34"", ""indication"": ""Hallucination"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43532,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1187,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7862,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43533,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1189,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Unknown"", ""doseAmount"": ""500"", ""indication"": ""Chemotherapy"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43534,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1190,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.7"", ""indication"": ""Growth retardation"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43535,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1191,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43536,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1193,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7249,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""120"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43537,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1194,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8099,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43538,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1196,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43539,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1199,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43540,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1200,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43541,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1201,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43542,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1201,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7882,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43543,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1207,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""280"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43544,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""145"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43545,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1218,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""21"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43546,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1220,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43547,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1221,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Transitional cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43548,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1222,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43549,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1223,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Encephalomyelitis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43550,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1224,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Primary immunodeficiency syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43551,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1225,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43552,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1226,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8352,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43553,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1226,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Dizziness"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1228,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43555,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1229,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""267"", ""indication"": ""Idiopathic pulmonary fibrosis"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43556,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1231,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8285,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""550"", ""indication"": ""Hepatic encephalopathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43557,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1233,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Hepatocellular carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43558,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1234,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43559,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1236,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Prostate cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43560,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1236,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8364,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Prostate cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43561,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1237,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8367,"{""doseUnit"": ""IU"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43562,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1238,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43563,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1239,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8375,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Prostate cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43564,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1239,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7435,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3"", ""indication"": ""Prostate cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43565,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1240,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""35"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43566,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1241,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1242,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43568,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1243,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43569,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1246,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""120"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43570,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1248,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8092,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43571,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1248,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8379,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Pain"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43572,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1248,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8380,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Pain"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1248,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7386,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pain"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43574,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1248,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7711,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Pain"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43575,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1249,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7458,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43576,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1251,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3.6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43577,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1252,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""17.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43578,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1255,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7901,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43579,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1256,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7905,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""420"", ""indication"": ""Rheumatoid arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43580,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1257,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8115,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""500"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43581,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1257,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8382,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Essential thrombocythaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43582,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1260,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43583,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1260,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43584,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1262,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8383,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""16"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43585,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1263,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7922,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43586,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1264,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8387,"{""doseUnit"": ""GTT"", ""route"": ""Ophthalmic"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43587,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1265,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1.8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43588,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1267,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43589,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1270,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8388,"{""doseUnit"": ""PCT"", ""route"": ""Rectal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43590,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1271,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43591,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1272,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43592,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1273,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""32"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43593,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1277,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43594,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1277,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43595,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1278,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1.4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43596,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1280,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Back pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43597,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1282,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43598,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1285,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43599,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1287,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""24"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43600,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1289,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8396,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""120"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43601,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1290,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8375,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43602,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1290,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7435,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43603,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1294,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8399,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""1200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43604,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1294,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8400,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43605,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1295,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.9"", ""indication"": ""Short stature"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43606,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1297,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8403,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12.5"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43607,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1298,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8404,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Weight decreased"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43608,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1299,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8364,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43609,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1299,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43610,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.55"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43611,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8188,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""160"", ""indication"": ""Hormone-refractory prostate cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43612,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1303,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43613,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1304,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8406,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Hereditary angioedema"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43614,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1306,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8201,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""61"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43615,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1307,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Pain in extremity"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43616,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1309,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43617,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1311,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43618,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43619,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1314,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43620,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8414,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2400"", ""indication"": ""Factor VIII deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43621,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1320,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Fallopian tube cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43622,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1320,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""15"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43623,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1321,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8415,"{""doseUnit"": ""MG"", ""route"": ""Transdermal"", ""doseAmount"": ""0.1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43624,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1323,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43625,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1323,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43626,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1323,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7996,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43627,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1324,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8417,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43628,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1324,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8418,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Pain"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43629,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1324,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8329,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Arthralgia"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43630,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1326,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8419,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1700"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43631,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1331,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8419,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43632,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1332,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8419,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43633,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1333,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8419,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43634,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1334,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8419,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2580"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43635,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1336,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8419,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43636,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1337,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8419,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43637,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1338,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8419,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43638,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1340,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Squamous cell carcinoma of the cervix"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43639,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1351,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43640,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1352,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43641,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1363,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43642,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1365,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.13"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43643,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1368,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Unknown"", ""doseAmount"": ""0.328"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43644,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1369,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43645,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1371,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8224,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43646,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1371,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Endometriosis"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43647,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1372,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8434,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Cystic fibrosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43648,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1372,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8020,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43649,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""214.2"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43650,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1830"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43651,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""122"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43652,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43653,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1376,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43654,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1379,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8444,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""17"", ""indication"": ""Plasma cell myeloma refractory"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43655,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1379,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.7"", ""indication"": ""Plasma cell myeloma refractory"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43656,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1379,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""17"", ""indication"": ""Plasma cell myeloma refractory"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43657,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1379,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""68"", ""indication"": ""Plasma cell myeloma refractory"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43658,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1380,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma in remission"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43659,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1381,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8446,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43660,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1381,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""784"", ""indication"": ""Follicular lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43661,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1382,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""35"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43662,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1383,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7394,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""34"", ""indication"": ""Hallucination"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43663,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1384,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43664,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1388,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43665,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1391,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""22.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43666,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8451,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.66"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43667,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1393,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Neoplasm malignant"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43669,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""4000"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43670,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8454,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43671,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7475,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Back pain"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43672,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1395,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8465,"{""doseUnit"": ""ML"", ""route"": ""Oral"", ""doseAmount"": ""1.8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43673,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1395,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8466,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""250"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43674,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1395,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8467,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43675,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1396,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43676,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8468,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""180"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43677,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1399,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3.2"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43678,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1400,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8469,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Secondary progressive multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43679,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1401,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8471,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43680,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43681,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1404,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1.4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43682,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1405,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8476,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""160"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43683,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1405,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8477,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""160"", ""indication"": ""Hypertension"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43684,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1406,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8478,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43685,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1407,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8040,"{""doseUnit"": ""UG"", ""route"": ""Intramuscular"", ""doseAmount"": ""7.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43686,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1411,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7733,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Hepatic cancer recurrent"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43687,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1412,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Bone marrow conditioning regimen"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43688,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1412,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Bone marrow conditioning regimen"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43689,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1413,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7249,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""240"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43690,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1414,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8486,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""200"", ""indication"": ""Systemic lupus erythematosus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43691,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1415,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8487,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43692,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1415,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8488,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43693,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8489,"{""doseUnit"": ""ML"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43694,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1417,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43695,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8139,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""284"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43696,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1419,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43697,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1420,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8139,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""284"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43698,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8139,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""284"", ""indication"": ""Unknown"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43699,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1423,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8492,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Gastric cancer"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43700,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1423,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7503,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Pulmonary embolism"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1423,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7173,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Gastric cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43702,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1425,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8328,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43703,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1426,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8493,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43704,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1429,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43705,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1430,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8139,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""284"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43706,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1431,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8500,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Hereditary angioedema"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43707,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1432,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1700"", ""indication"": ""Bone marrow conditioning regimen"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43708,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1432,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""47.5"", ""indication"": ""Bone marrow conditioning regimen"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43709,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1433,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8335,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43710,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1434,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8502,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""148"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43711,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1436,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8503,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""5.963"", ""indication"": ""Pain"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43712,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1436,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8504,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""9.981"", ""indication"": ""Pain"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43713,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1438,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Cervix carcinoma stage III"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43714,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1440,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8364,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43715,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1442,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Short stature"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43716,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1443,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8506,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""12"", ""indication"": ""Mucopolysaccharidosis I"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43717,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8507,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43718,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1445,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8508,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43719,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1445,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8509,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""450"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43720,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7535,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Pain"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43721,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1447,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8247,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43722,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1448,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1.7"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43723,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1449,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7850,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Bronchial neoplasm"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43724,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1450,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7504,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43725,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1450,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7262,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1200"", ""indication"": ""Pain"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43726,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1451,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43727,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1452,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5"", ""indication"": ""Asthma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43728,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1454,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7504,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Back pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43729,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1454,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8418,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Back pain"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43730,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1455,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8194,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43731,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1456,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8513,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Spinal muscular atrophy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43732,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1457,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43733,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1458,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8509,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""450"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43734,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1458,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8508,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""45"", ""indication"": ""Metastatic malignant melanoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43735,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1461,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43736,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1464,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43737,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1466,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""18"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43738,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1467,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43739,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1467,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Primary immunodeficiency syndrome"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43740,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1469,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43741,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1470,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43742,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1472,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43743,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1472,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7539,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""410"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43744,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1472,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8089,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1010"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43745,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1473,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8054,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""90"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43746,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1474,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8354,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""24"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43747,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1475,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8242,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""450"", ""indication"": ""Synovial sarcoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43748,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""22"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43749,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1480,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43750,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1485,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43751,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1487,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8518,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43752,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1488,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43753,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1488,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43754,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1489,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43755,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1490,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43756,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7394,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""34"", ""indication"": ""Hallucination"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43757,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8034,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""137"", ""indication"": ""Dyskinesia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43758,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1492,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8520,"{""doseUnit"": ""MG/KG"", ""route"": ""Unknown"", ""doseAmount"": ""0.3"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43759,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1492,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8185,"{""doseUnit"": ""MG/M**2"", ""route"": ""Unknown"", ""doseAmount"": ""1000"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43760,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1492,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8521,"{""doseUnit"": ""MG/M**2"", ""route"": ""Unknown"", ""doseAmount"": ""125"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43761,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1493,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""500"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43762,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1493,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""403"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43763,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1493,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1431"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1493,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8526,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Hypertension"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43765,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1495,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43766,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1495,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7719,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2000"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43767,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1498,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7687,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43768,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1499,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8530,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""0.65"", ""indication"": ""Metastatic renal cell carcinoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43769,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1499,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8531,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Metastatic renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43770,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1500,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7681,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43771,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1501,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8535,"{""doseUnit"": ""DF"", ""route"": ""Vaginal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43772,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1502,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1503,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43774,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1504,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""4.437"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43775,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1505,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""27.5"", ""indication"": ""Congenital hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43776,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1508,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8538,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43777,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1511,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""4.13"", ""indication"": ""Unknown"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43778,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1512,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43779,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1513,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8541,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43780,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1514,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8143,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Diabetes mellitus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43781,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1514,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8543,"{""doseUnit"": ""DF"", ""route"": ""Intramuscular"", ""doseAmount"": ""1"", ""indication"": ""Immunisation"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43782,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1514,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8544,"{""doseUnit"": ""ML"", ""route"": ""Intramuscular"", ""doseAmount"": ""0.5"", ""indication"": ""Immunisation"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43783,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1515,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Other"", ""doseAmount"": ""0.65"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43784,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1518,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Immunodeficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43785,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1519,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43786,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1521,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Unknown"", ""doseAmount"": ""0.24"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43787,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1522,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""80"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43788,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1523,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8381,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""750"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43789,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1525,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""59.8"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43790,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1526,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Unknown"", ""doseAmount"": ""0.492"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1528,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Primary immunodeficiency syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43792,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1529,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43793,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1531,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43794,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1533,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8399,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""1400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43795,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1534,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7681,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43796,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1535,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8417,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43797,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1535,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8190,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43798,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1536,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2.4"", ""indication"": ""Blood growth hormone abnormal"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43799,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1537,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.208"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1538,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8335,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43801,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1539,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8548,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43802,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1540,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43803,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1540,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43804,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1541,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.6"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43805,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1544,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Illness"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43806,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1545,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""4.5"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43807,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1546,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.24"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43808,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1548,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""3.25"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43809,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1549,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8240,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43810,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1552,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8552,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Bipolar disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43811,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1553,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8553,"{""doseUnit"": ""ML"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25.2"", ""indication"": ""Endocrine ophthalmopathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43812,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1555,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43813,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1556,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8553,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""800"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43814,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1557,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43815,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1558,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""75"", ""indication"": ""Myelodysplastic syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43816,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1565,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8559,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Hypothyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43817,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1566,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8548,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43818,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8561,"{""doseUnit"": ""DF"", ""route"": ""Transplacental"", ""doseAmount"": ""1"", ""indication"": ""HIV infection"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43819,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1570,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8487,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""4200"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43820,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1571,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8222,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43821,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1571,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8562,"{""doseUnit"": ""MG"", ""route"": ""Other"", ""doseAmount"": ""300"", ""indication"": ""Hereditary angioedema"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43822,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1572,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.13"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43823,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""15"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""70"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43825,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1440"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43826,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43827,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7355,"{""doseUnit"": ""IU"", ""route"": ""Intramuscular"", ""doseAmount"": ""3600"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43828,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1574,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8471,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Axial spondyloarthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43829,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1575,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43830,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1576,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43831,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1581,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8569,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43832,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1582,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG/KG"", ""route"": ""Unknown"", ""doseAmount"": ""0.05"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43833,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1583,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43834,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1586,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1.2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43835,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1588,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43836,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1589,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8506,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""42"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43837,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1590,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43838,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1591,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1.625"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43839,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1593,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43840,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1593,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7271,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43841,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1594,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7860,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""14"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43842,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1594,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Metastatic renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43843,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1595,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8578,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43844,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1598,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Crohn's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43845,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1601,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43846,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1601,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43847,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1601,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43848,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1602,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43849,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1604,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG/KG"", ""route"": ""Unknown"", ""doseAmount"": ""0.05"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43850,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1606,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8587,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2000"", ""indication"": ""Factor VIII deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43851,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1612,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43852,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1613,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43853,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1613,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7882,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1617,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8500,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43855,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1617,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8562,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43856,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1618,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7850,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43857,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1619,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8224,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43858,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1619,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43859,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1620,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7252,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43860,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1620,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8517,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""6"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43861,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1620,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43862,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1621,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8335,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Cardiac failure"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43863,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1622,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7661,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""320"", ""indication"": ""Hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43864,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1623,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8335,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""49.51"", ""indication"": ""Cardiomyopathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43865,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1624,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8517,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""6"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43866,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1624,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7877,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1624,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43868,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1624,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7922,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1625,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7850,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""90"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43870,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1626,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""174"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43871,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1626,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43872,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1626,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""109.6"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43873,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1626,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1643"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43874,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1627,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""375"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43875,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1627,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8185,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43876,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1627,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43877,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1628,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8005,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""720"", ""indication"": ""Metastatic malignant melanoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43878,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1631,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43879,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1635,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8058,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""120"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1636,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43881,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1636,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""100"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43882,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1637,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""4"", ""indication"": ""Infection"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43883,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1638,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43884,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1639,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7594,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""320"", ""indication"": ""Hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43885,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1639,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7661,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""320"", ""indication"": ""Hypertension"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43886,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1641,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8513,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Spinal muscular atrophy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43887,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1642,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.54"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1643,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""153"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1643,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""51"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43890,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1643,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8364,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1000"", ""indication"": ""Bladder cancer"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43891,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1645,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7996,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""32.5"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43892,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1647,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7681,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43893,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1649,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8610,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""125"", ""indication"": ""Dermatomyositis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43894,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1650,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.25"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43895,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1651,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8611,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""3.6"", ""indication"": ""HER2 negative breast cancer"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43896,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1652,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7681,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43897,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1655,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7661,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""320"", ""indication"": ""Hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43898,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1656,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8612,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""320"", ""indication"": ""Hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43899,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1656,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8613,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""160"", ""indication"": ""Hypertension"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43900,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1656,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8614,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""160"", ""indication"": ""Hypertension"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43901,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1659,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8577,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43902,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1662,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""174"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43903,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1662,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1643"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43904,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1662,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""109.6"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43905,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1662,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43906,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1665,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.86"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43907,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1666,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""11"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43908,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7882,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43909,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1670,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43910,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1670,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43911,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1672,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""170"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43912,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1672,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43913,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1672,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43914,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1672,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2280"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1672,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7355,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5700"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43916,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1673,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43917,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1674,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43918,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1677,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8465,"{""doseUnit"": ""ML"", ""route"": ""Oral"", ""doseAmount"": ""2.7"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43919,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1678,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8465,"{""doseUnit"": ""ML"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Severe myoclonic epilepsy of infancy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43920,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1680,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8465,"{""doseUnit"": ""ML"", ""route"": ""Oral"", ""doseAmount"": ""4.3"", ""indication"": ""Seizure"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43921,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1681,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8623,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43922,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1681,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7435,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""480"", ""indication"": ""Fallopian tube cancer stage III"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43923,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1682,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7437,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43924,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1685,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43925,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1686,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8222,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43926,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1686,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8562,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""19""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43927,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1687,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1688,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7437,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43929,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1689,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8468,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""90"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43930,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1690,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8210,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Fallopian tube cancer stage III"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43931,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1691,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8222,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43932,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1692,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7248,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43933,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1692,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8556,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43934,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1692,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8628,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43935,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1692,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8629,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43936,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1693,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43937,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1694,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43938,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1695,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8636,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5.4"", ""indication"": ""Breast cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43939,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1696,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8364,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43940,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1696,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43941,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8640,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43942,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1703,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43943,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1703,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""75"", ""indication"": ""Myelodysplastic syndrome"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43944,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1704,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43945,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1709,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Squamous cell carcinoma of head and neck"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43946,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1710,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Crohn's disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43947,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1711,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43948,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1712,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43949,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1714,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Asthma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43950,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1714,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7719,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Asthma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43951,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1715,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43952,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1716,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Fibromyalgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43953,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1717,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8483,"{""doseUnit"": ""ML"", ""route"": ""Other"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43954,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1717,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7181,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43955,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1719,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""125"", ""indication"": ""Breast cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43956,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1720,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.36"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43957,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1721,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7384,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Colorectal adenocarcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43958,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1722,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8650,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""11200"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43959,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1722,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""224"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43960,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1722,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7991,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""11200"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43961,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1722,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7473,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2250.2"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43962,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1722,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""225"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43963,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1722,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""850"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43964,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1726,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8247,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Anxiety disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43965,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1728,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8224,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43966,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1728,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43967,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1729,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43968,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1733,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Primary immunodeficiency syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43969,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1735,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43970,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1736,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43971,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1744,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8401,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43972,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1744,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""9"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43973,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1747,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1750,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8660,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43975,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1751,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7876,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43976,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1753,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8506,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""24"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43977,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1754,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""800"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43978,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1754,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43979,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1755,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43980,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1758,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8669,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1200"", ""indication"": ""Colorectal cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43981,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1760,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7435,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43982,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1760,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8375,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43983,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1762,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8671,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43984,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1762,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8399,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43985,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1765,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Relapsing multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43986,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1766,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8557,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43987,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1767,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7703,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""6"", ""indication"": ""Hormone receptor positive HER2 negative breast cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43988,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1768,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7901,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""240"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43989,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1771,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""132"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43990,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8194,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43991,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7248,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43992,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1774,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8099,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43993,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1774,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43994,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1775,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43995,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1775,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8042,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43996,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1778,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8681,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43997,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1778,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8367,"{""doseUnit"": ""IU"", ""route"": ""Subcutaneous"", ""doseAmount"": ""70"", ""indication"": ""Type 2 diabetes mellitus"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43998,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1779,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8335,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:43999,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1780,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44000,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1781,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7611,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44001,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1782,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""150"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44002,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1782,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7643,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""15"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44003,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1782,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""95"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44004,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1782,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2000"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44005,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1782,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""103.6"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44006,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1782,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7355,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3750"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44007,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1783,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44008,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1784,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8500,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44009,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1784,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8562,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44010,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1785,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""450"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44011,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1785,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44012,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1786,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Primary immunodeficiency syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44013,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1787,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1788,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""800"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44015,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1788,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""55"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44016,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1789,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44017,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1790,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8691,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44018,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1790,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""115"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44019,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1790,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44020,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""85"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44021,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8294,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44022,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8702,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous bolus"", ""doseAmount"": ""400"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44023,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1792,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8703,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""134"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44024,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1792,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7473,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1070"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44025,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1793,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7437,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Chronic myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44026,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1795,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7464,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""12.5"", ""indication"": ""Hypertension"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44027,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1797,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8705,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""11340"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44028,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1798,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7860,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44029,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1799,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44030,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8381,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""750"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44031,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1801,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""600"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44032,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1801,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""60"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44033,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1804,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8548,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44034,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1808,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8725,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""36"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44035,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1809,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44036,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1811,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7235,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.3"", ""indication"": ""Hot flush"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44037,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1812,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Colon cancer metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44038,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1818,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44039,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1819,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8321,"{""doseUnit"": ""IU"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5000"", ""indication"": ""Prophylaxis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44040,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1820,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7249,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""240"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44041,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1820,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7238,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Trigeminal neuralgia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44042,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1820,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Trigeminal neuralgia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44043,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1820,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8629,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""900"", ""indication"": ""Trigeminal neuralgia"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44044,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1821,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8735,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44045,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1822,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8736,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""Cervix cancer metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44046,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1823,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7437,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44047,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1825,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7681,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44048,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1826,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""4"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44049,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1827,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8055,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Back pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44050,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1828,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8368,"{""doseUnit"": ""MG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.33"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44051,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1829,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7234,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44052,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1830,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7882,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44053,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1832,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7905,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""162"", ""indication"": ""Giant cell arteritis"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44054,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1835,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""480"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44055,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1835,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8738,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44056,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1836,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""470"", ""indication"": ""Follicular lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44057,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1836,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""37.5"", ""indication"": ""Follicular lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44058,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1838,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8739,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44059,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1839,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8737,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""125"", ""indication"": ""Psoriatic arthropathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44060,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1840,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7365,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44061,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1841,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8749,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44062,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1841,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44063,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1842,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44064,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1843,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44065,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1846,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""753.8"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44066,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1846,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""450"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44067,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1846,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7991,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10050"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44068,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1846,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8650,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10050"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44069,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1847,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7983,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""4"", ""indication"": ""Renal transplant"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44070,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1850,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""843"", ""indication"": ""Hepatocellular carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44071,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1851,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44072,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44073,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1856,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44074,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1857,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7213,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44075,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1858,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44076,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1860,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8670,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Illness"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44077,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1863,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44078,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1866,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.2"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44079,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1868,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8766,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.46"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44080,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8098,"{""doseUnit"": ""DF"", ""route"": ""Vaginal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44081,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1877,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""50"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44082,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44083,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""15"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44084,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""103.6"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44085,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44086,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2000"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44087,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""95"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44088,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1881,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""267"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44089,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1882,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""170"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44090,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1882,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44091,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1882,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44092,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1882,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2280"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44093,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1882,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7355,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5700"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44094,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1883,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8772,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44095,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1884,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8236,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44096,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1884,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8037,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""HER2 negative breast cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44097,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1884,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7707,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Breast cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44098,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8506,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""24"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44099,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8671,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44100,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1890,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8776,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Adrenocortical carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44101,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1892,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8218,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Renal disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44102,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1892,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7432,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""500"", ""indication"": ""Granulomatosis with polyangiitis"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44103,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1893,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8577,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44104,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1897,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44105,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1898,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""32"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44106,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1899,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3"", ""indication"": ""Leiomyosarcoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44107,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1899,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8364,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Leiomyosarcoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44108,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1903,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8787,"{""doseUnit"": ""MG"", ""route"": ""Transplacental"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44109,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1904,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44110,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1905,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7901,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""247.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1907,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8492,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2000"", ""indication"": ""Metastatic malignant melanoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44112,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1908,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8671,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44113,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1909,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8788,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44114,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1911,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44115,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1913,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44116,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1916,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.8"", ""indication"": ""Malnutrition"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44117,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1917,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44118,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1918,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8335,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44119,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1919,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8500,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44120,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1920,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8406,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44121,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1921,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8789,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44122,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1924,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8790,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44123,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1925,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44124,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1927,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2.8"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44125,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1929,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8506,"{""doseUnit"": ""MG/KG"", ""route"": ""Unknown"", ""doseAmount"": ""0.53"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44126,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1930,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44127,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1932,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3.9"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44128,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1933,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8335,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44129,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1934,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44130,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1938,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44131,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1939,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8669,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1600"", ""indication"": ""Colorectal cancer"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44132,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1940,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""3.5"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44133,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1941,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG/KG"", ""route"": ""Unknown"", ""doseAmount"": ""0.05"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44134,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1948,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.5"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44135,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1949,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8806,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""7000"", ""indication"": ""Factor IX deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44136,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1950,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""85"", ""indication"": ""Colon cancer stage III"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44137,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1950,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8294,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Colon cancer stage III"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44138,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1950,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8702,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous bolus"", ""doseAmount"": ""400"", ""indication"": ""Colon cancer stage III"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44139,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1954,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8218,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44140,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1955,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7920,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44141,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1955,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44142,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1955,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44143,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1956,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8577,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44144,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1957,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1.6"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44145,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1958,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.45"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44146,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1959,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8809,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""44"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44147,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1964,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8811,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44148,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1965,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8812,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44149,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1965,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8813,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Breast cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44150,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1966,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8814,"{""doseUnit"": ""UG"", ""route"": ""Intra-uterine"", ""doseAmount"": ""14"", ""indication"": ""Contraception"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44151,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1967,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7319,"{""doseUnit"": ""IU"", ""route"": ""Unknown"", ""doseAmount"": ""16"", ""indication"": ""Type 1 diabetes mellitus"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44152,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1971,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.272"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44153,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1972,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8815,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""15"", ""indication"": ""Iron deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44154,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1973,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44155,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1973,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8042,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44156,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8809,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""44"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44157,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1975,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8817,"{""doseUnit"": ""MG"", ""route"": ""Intravenous bolus"", ""doseAmount"": ""100"", ""indication"": ""Iron deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44158,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1976,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44159,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1977,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""11"", ""indication"": ""Rheumatoid arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44160,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1980,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8118,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.25"", ""indication"": ""Relapsing-remitting multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44161,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1982,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1984,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8823,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1987,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8826,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Invasive breast carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44164,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1987,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8827,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3.6"", ""indication"": ""Invasive breast carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44165,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1989,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7394,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""34"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44166,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1991,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8500,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1991,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8562,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44168,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1992,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Hidradenitis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44169,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1996,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8776,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Colon cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44170,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1998,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8194,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44171,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:1998,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8556,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44172,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2001,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8838,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44173,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2002,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7997,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44174,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2003,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8845,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44175,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2003,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7279,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Prostate cancer metastatic"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44176,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2008,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7850,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""90"", ""indication"": ""Acoustic neuroma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44177,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2010,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8846,"{""doseUnit"": ""MCI"", ""route"": ""Unknown"", ""doseAmount"": ""200.88"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44178,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2013,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44179,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""15"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44180,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""103.6"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44181,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8493,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""95"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44182,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44183,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44184,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7355,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3750"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44185,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2016,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8848,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""960"", ""indication"": ""K-ras gene mutation"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44186,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2019,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""85"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44187,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2019,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8294,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44188,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2019,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8702,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous bolus"", ""doseAmount"": ""400"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44189,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2021,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8749,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""900"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44190,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2021,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8748,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""800"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44191,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2021,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""400"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44192,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2024,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8850,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""130.892"", ""indication"": ""Chemotherapy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44193,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2024,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8851,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""4490"", ""indication"": ""Chemotherapy"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44194,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2024,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""240"", ""indication"": ""Chemotherapy"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44195,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2025,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44196,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2026,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44197,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2026,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8852,"{""doseUnit"": ""UG"", ""route"": ""Intramuscular"", ""doseAmount"": ""58.75"", ""indication"": ""Skin cancer"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44198,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2027,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7850,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""180"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44199,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2028,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7905,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""162"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44200,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2031,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8691,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44201,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2031,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""135"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44202,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2031,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44203,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2035,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7335,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44204,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2035,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7267,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44205,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2038,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Other"", ""doseAmount"": ""0.45"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44206,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2040,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.018"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44207,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2043,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44208,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2044,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8859,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44209,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2044,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.7"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44210,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2044,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""12"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44211,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2044,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7920,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44212,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2045,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7893,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44213,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2046,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7681,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44214,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2047,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8399,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44215,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2050,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8862,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""165"", ""indication"": ""Occipital neuralgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44216,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2051,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8237,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2051,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7348,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Pain"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44218,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2054,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44219,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2056,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8099,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44220,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2056,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Hormone-refractory prostate cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44221,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2058,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""175"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44222,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2058,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""15"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44223,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2060,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7996,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44224,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2060,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7553,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44225,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2069,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8873,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""14"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44226,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2070,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8702,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous bolus"", ""doseAmount"": ""400"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44227,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2070,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8294,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44228,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2070,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""85"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44229,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2072,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8874,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""250"", ""indication"": ""Soft tissue sarcoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44230,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2075,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8118,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44231,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2076,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44232,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2077,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8876,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44233,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2077,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44234,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2078,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7882,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44235,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2079,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7961,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Hypothyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44236,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2080,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8817,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Anaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44237,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2080,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7233,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44238,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2083,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8881,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""105"", ""indication"": ""Gastrointestinal carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44239,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2086,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7502,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44240,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2087,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8099,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Metastatic neoplasm"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44241,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2089,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8883,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44242,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2093,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8465,"{""doseUnit"": ""ML"", ""route"": ""Oral"", ""doseAmount"": ""2.2"", ""indication"": ""Severe myoclonic epilepsy of infancy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44243,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2094,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8465,"{""doseUnit"": ""ML"", ""route"": ""Oral"", ""doseAmount"": ""3.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44244,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2096,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8201,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""61"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44245,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2098,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7893,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44246,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2101,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7961,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Hypoparathyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44247,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2103,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8099,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44248,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2106,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8892,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44249,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2107,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7502,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44250,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2108,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""500"", ""indication"": ""Lung neoplasm malignant"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44251,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2108,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Lung neoplasm malignant"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44252,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2109,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8896,"{""doseUnit"": ""UG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""44"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44253,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2110,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8681,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44254,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44255,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2114,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8900,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44256,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2114,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8901,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Myasthenic syndrome"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44257,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2116,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""172.5"", ""indication"": ""Colon cancer stage III"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44258,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2116,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8294,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""810"", ""indication"": ""Colon cancer stage III"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44259,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2116,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8702,"{""doseUnit"": ""MG"", ""route"": ""Intravenous bolus"", ""doseAmount"": ""5675"", ""indication"": ""Colon cancer stage III"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44260,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2117,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8749,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44261,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2117,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8748,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44262,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2117,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44263,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2118,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8903,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Triple negative breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44264,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2122,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44265,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2123,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8548,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44266,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2124,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44267,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2124,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""500"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44268,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2124,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""269"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44269,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2124,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""790"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44270,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2129,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""375"", ""indication"": ""Follicular lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44271,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2133,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7850,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""180"", ""indication"": ""Lung neoplasm malignant"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44272,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2134,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44273,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2135,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8766,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.92"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44274,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2144,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44275,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2146,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7499,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44276,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2147,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""35"", ""indication"": ""Bladder cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44277,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2151,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8381,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""750"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44278,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2152,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44279,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2153,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8807,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""14"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44280,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2154,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44281,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2158,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44282,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2158,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8914,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44283,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2159,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""176"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44284,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2159,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1612.5"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44285,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2159,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""108"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2159,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44287,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2160,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8489,"{""doseUnit"": ""ML"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44289,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2164,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8776,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""65"", ""indication"": ""Epithelioid mesothelioma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44290,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2166,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8918,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44291,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2166,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8919,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2.5"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44292,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2166,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44293,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8921,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44294,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2170,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8034,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""274"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44295,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2170,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7183,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6.25"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44296,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2171,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44297,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2176,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44298,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2177,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""172"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44299,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2178,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2179,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7170,"{""doseUnit"": ""MG/KG"", ""route"": ""Transplacental"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44301,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2182,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2182,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""15"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44303,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2182,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44304,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2182,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44305,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2182,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44306,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2183,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44307,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2184,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44308,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2186,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8500,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44309,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2186,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7996,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""65"", ""indication"": ""Myasthenia gravis"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44310,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2188,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44311,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2192,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""500"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2192,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8935,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""220"", ""indication"": ""Breast cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2193,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7759,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1.5"", ""indication"": ""Papillary thyroid cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44314,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2194,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2195,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44316,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2200,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2201,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8404,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Weight decreased"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44318,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2203,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44319,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2204,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""188"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44320,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2206,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8367,"{""doseUnit"": ""IU"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Type 2 diabetes mellitus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44321,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2207,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8946,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""44"", ""indication"": ""Nephroblastoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44322,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2207,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8947,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""90"", ""indication"": ""Nephroblastoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44323,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2208,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44324,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2209,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8948,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44325,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2210,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8500,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44326,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2210,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8562,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44327,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2210,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7719,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2211,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44329,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2212,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""69"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44330,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2212,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8949,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2.1"", ""indication"": ""Leiomyosarcoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44331,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2213,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Contraception"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44332,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""498"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44333,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""49.8"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44334,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7922,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44335,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7222,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44336,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44337,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2220,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8958,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44338,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2220,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8959,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44339,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2220,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8960,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""80"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44340,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2221,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44341,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2223,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""350"", ""indication"": ""Refractory cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44342,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2223,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""250"", ""indication"": ""Recurrent cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44343,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2223,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8961,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""0.75"", ""indication"": ""Recurrent cancer"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44344,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2224,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8964,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44345,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2225,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7782,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Cerebrovascular accident prophylaxis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44346,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2227,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""35"", ""indication"": ""Polyneuropathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44347,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2228,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7782,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Thrombosis"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44348,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2229,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.075"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44349,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2230,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7183,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""12.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44350,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2230,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8034,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""137"", ""indication"": ""Dyskinesia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44351,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2231,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8335,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Cardiac failure congestive"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44352,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2232,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7681,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44353,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2232,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7499,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1000"", ""indication"": ""Multiple sclerosis"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44354,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2234,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44355,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2235,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""296.4"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44356,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2236,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8381,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""750"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44357,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2237,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Prostate cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44358,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2238,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8544,"{""doseUnit"": ""ML"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44359,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2239,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7205,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""60"", ""indication"": ""Psychotic disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44360,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2240,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44361,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2240,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44362,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2240,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44363,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2241,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""280"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44364,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2241,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8240,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44365,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2245,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7965,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""90"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44366,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2249,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3.75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44367,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2250,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8977,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Haematological malignancy"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44368,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2252,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44369,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2252,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""500"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44370,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2254,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44371,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2256,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44372,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2256,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""500"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44373,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2256,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""301"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2258,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44375,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2259,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44376,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2261,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7249,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""240"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44377,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2262,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1572"", ""indication"": ""Hepatocellular carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44378,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2262,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8982,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Hepatocellular carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44379,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2264,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44380,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2267,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7502,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44381,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2268,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8218,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""625"", ""indication"": ""Factor VIII deficiency"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44382,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2268,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Factor VIII deficiency"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44383,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2270,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44384,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2270,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44385,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2270,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7335,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44386,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2279,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44387,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2280,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44388,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2282,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7252,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44389,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2282,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8918,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""60"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44390,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2284,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44391,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2285,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44393,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8918,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7360,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44395,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2287,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7360,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44396,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2287,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7252,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44397,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2287,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8918,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9003,"{""doseUnit"": ""MG"", ""route"": ""Other"", ""doseAmount"": ""0.2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44399,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7631,"{""doseUnit"": ""MG"", ""route"": ""Other"", ""doseAmount"": ""123.2"", ""indication"": ""Pneumocystis jirovecii pneumonia"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44400,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9004,"{""doseUnit"": ""MG"", ""route"": ""Other"", ""doseAmount"": ""1.25"", ""indication"": ""Immunosuppression"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44401,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7279,"{""doseUnit"": ""MG"", ""route"": ""Other"", ""doseAmount"": ""12.3"", ""indication"": ""Immunosuppression"", ""drugSequence"": ""27""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44402,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Oral candidiasis"", ""drugSequence"": ""31""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2289,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8174,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""320"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44404,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2292,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG/M**2"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44405,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2292,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""12.5"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44406,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2292,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7352,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.4"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44407,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2295,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8670,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Malignant connective tissue neoplasm"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44408,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2298,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44409,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2299,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8004,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""84"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44410,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2304,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44411,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2305,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9011,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44412,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2305,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG/M**2"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""T-cell type acute leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44413,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2305,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9012,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""T-cell type acute leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44414,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2305,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7352,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.5"", ""indication"": ""T-cell type acute leukaemia"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44415,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2306,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9013,"{""doseUnit"": ""UG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Type 2 diabetes mellitus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2306,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7660,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Blood cholesterol abnormal"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44417,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2310,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9009,"{""doseUnit"": ""PCT"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2311,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44419,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44420,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7877,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7922,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7495,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44423,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44424,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7366,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44425,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44426,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44427,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2314,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44428,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2314,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44429,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2314,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44430,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.33"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44431,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44432,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2318,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Colon cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44433,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2319,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44434,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2320,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44435,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2320,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""12.5"", ""indication"": ""Crohn's disease"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44436,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2321,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Recurrent cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2321,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""47"", ""indication"": ""Recurrent cancer"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44438,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2321,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.5"", ""indication"": ""Recurrent cancer"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44439,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2321,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9016,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2500"", ""indication"": ""Recurrent cancer"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44440,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2324,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Contraception"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44441,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2325,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44442,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2330,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""840"", ""indication"": ""Ovarian cancer recurrent"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44443,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2330,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Ovarian cancer recurrent"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2331,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44445,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2332,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2"", ""indication"": ""Hereditary angioedema with normal C1 esterase inhibitor"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2333,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8004,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""84"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44447,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2337,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8004,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""52"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44448,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2338,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.08"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44449,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2338,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8400,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44450,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2340,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7983,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""600"", ""indication"": ""Liver transplant"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44451,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2340,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7321,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""250"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44452,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2343,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44453,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2344,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9027,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44454,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2345,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8197,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""120"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44455,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2350,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7365,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44456,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2352,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9028,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""840"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44457,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2352,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9029,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""880"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44458,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2352,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9030,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""316.8"", ""indication"": ""Adenocarcinoma of colon"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44459,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2353,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44460,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2354,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44461,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2354,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8220,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Colitis ulcerative"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44462,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2358,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44463,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2359,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44464,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2361,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44465,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2364,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44466,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2367,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8399,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Pulmonary hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44467,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2368,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44468,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2368,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44469,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2369,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8766,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.92"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44470,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2371,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""240"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44471,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2371,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""70"", ""indication"": ""Pancreatic carcinoma"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44472,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2372,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7984,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Asthma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44473,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2373,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44474,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44475,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2375,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8253,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44476,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2377,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9039,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44477,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2380,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44478,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2380,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Crohn's disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2380,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8100,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Crohn's disease"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44480,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2381,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8509,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""45"", ""indication"": ""Hairy cell leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44481,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2382,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8749,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44482,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2382,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44483,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2383,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9041,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Adenocarcinoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44484,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2384,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9042,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Gastrointestinal stromal tumour"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44485,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2388,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44486,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3.53"", ""indication"": ""Leiomyosarcoma metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44487,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8949,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.7"", ""indication"": ""Leiomyosarcoma metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44488,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2393,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1139"", ""indication"": ""Transitional cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44489,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2395,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44490,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2399,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7435,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""240"", ""indication"": ""Pancreatic carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2401,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44492,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2405,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8513,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44493,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2412,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44494,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2412,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""15"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44495,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2412,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""90"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44496,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2412,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1760"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44497,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2413,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44498,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2414,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8884,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Pneumonia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44499,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2415,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7931,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""160"", ""indication"": ""Hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44500,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2415,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9057,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""160"", ""indication"": ""Hypertension"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44501,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8118,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44502,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2419,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44503,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2420,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.03"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44504,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Mantle cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44505,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9062,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""173"", ""indication"": ""Mantle cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44506,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44507,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44508,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2.3"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44509,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2425,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8489,"{""doseUnit"": ""ML"", ""route"": ""Unknown"", ""doseAmount"": ""2.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44510,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2426,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44511,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2427,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8538,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44512,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2428,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""17"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44513,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2428,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""17"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44514,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2432,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8399,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44515,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2432,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7944,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary hypertension"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44516,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44517,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2441,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8681,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.75"", ""indication"": ""Diabetes mellitus"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44518,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2443,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8058,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""16000"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44519,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7922,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44520,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44521,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2445,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8827,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3.6"", ""indication"": ""HER2 positive breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44522,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7920,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Follicular lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44523,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2447,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8766,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.23"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44524,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2449,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44525,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2449,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""175"", ""indication"": ""Endometrial cancer"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44526,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2450,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7920,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44527,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2450,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44528,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2451,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44529,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2457,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7836,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44530,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2457,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9085,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44531,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2458,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.099"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44532,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2461,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44533,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2461,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44534,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2463,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""70"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44535,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2465,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8004,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""84"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44536,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2465,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Alcohol use disorder"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44537,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2466,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.023"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44538,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2467,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44539,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2469,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8123,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""17.65"", ""indication"": ""Mucopolysaccharidosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44540,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2470,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8085,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Metastatic malignant melanoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44541,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2472,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44542,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2476,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""240"", ""indication"": ""Gallbladder cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44543,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2476,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9092,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Gallbladder cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44544,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2476,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9030,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""70"", ""indication"": ""Gallbladder cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44545,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2477,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8478,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Non-small cell lung cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44546,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2478,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44547,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44548,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2483,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44549,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2483,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44550,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2487,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44551,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2488,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44552,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2489,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44553,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2489,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""500"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2489,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""285"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44555,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2490,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44556,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9094,"{""doseUnit"": ""MG"", ""route"": ""Other"", ""doseAmount"": ""0.5"", ""indication"": ""Neovascular age-related macular degeneration"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44557,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2493,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44558,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2494,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""37"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44559,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2495,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""30"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44560,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2495,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""500"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44561,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2497,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9101,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""360"", ""indication"": ""Malignant neoplasm progression"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44562,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2499,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9102,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44563,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2500,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8735,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44564,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2504,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""138"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44565,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2504,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7473,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1824"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44566,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2504,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8454,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""160"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2504,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""700"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44568,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2507,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7335,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44569,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2508,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8757,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""0.2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44570,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2509,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""67.2"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44571,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2511,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9108,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44572,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2513,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9110,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""325"", ""indication"": ""K-ras gene mutation"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2513,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9111,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.5"", ""indication"": ""K-ras gene mutation"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44574,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2515,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44575,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2517,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7920,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44576,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2517,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44577,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2517,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9011,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44578,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2518,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8004,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""84"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44579,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2521,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Fallopian tube cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44580,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2521,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9115,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Fallopian tube cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44581,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2526,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG/M**2"", ""route"": ""Unknown"", ""doseAmount"": ""375"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44582,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2526,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""57"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44583,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2526,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7352,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.4"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44584,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2526,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""286"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44585,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2526,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous bolus"", ""doseAmount"": ""2140"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44586,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2526,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""140"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44587,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2528,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8004,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""84"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44588,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2529,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9011,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44589,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2529,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma refractory"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44590,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2529,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9120,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44591,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2530,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44592,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2532,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Alcohol use disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44593,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2533,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44594,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2533,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7922,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44595,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2533,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7877,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44596,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2534,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44597,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2536,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44598,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2537,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.13"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44599,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2538,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9121,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44600,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2538,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7321,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""500"", ""indication"": ""Prophylaxis against transplant rejection"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44601,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2538,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9122,"{""doseUnit"": ""MG/KG"", ""route"": ""Unknown"", ""doseAmount"": ""1.5"", ""indication"": ""Prophylaxis against transplant rejection"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44602,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2543,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8681,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.75"", ""indication"": ""Glycosylated haemoglobin increased"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44603,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2544,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44604,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2545,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9124,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.2"", ""indication"": ""Glioblastoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44605,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2545,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Glioblastoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44606,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2546,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7245,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44607,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2546,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""91"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44608,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2546,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1360"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44609,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2546,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7279,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44610,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2547,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44611,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2548,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44612,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2551,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8365,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""45"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44613,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2551,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7335,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Aortic valve disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44614,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""152"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44615,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1500"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44616,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""102"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44617,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44618,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2555,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.023"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44619,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2556,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.77"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44620,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2557,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8517,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44621,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2558,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44622,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2558,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7539,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""510"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44623,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2558,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""276"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44624,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2558,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44625,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2559,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9044,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44626,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2560,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9131,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""0.5"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44627,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2562,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8340,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44628,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2565,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9136,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""K-ras gene mutation"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44629,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44630,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2568,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Monoclonal gammopathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44631,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2569,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8578,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44632,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2570,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7862,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44633,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2571,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9138,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44634,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2572,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8817,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44635,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9139,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44636,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2574,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44637,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2575,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44638,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2577,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""125"", ""indication"": ""Breast cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44639,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2578,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1.6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44640,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2579,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8551,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""700"", ""indication"": ""COVID-19"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44641,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2580,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9144,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Hypertension"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44642,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2580,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8232,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""160"", ""indication"": ""Blood potassium decreased"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44643,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2580,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7594,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""160"", ""indication"": ""Hypertension"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44644,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2581,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9146,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""35.6"", ""indication"": ""Narcolepsy"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44645,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2582,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8308,"{""doseUnit"": ""Unknown"", ""route"": ""Respiratory (inhalation)"", ""doseAmount"": ""180"", ""indication"": ""Asthma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44646,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2583,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8551,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""700"", ""indication"": ""COVID-19"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44647,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2584,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8544,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44648,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2586,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8468,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""180"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44649,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2587,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44650,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2588,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8321,"{""doseUnit"": ""IU"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5000"", ""indication"": ""Prophylaxis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44651,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2590,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44652,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2592,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9147,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44653,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2593,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8618,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44654,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2598,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8364,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Metastatic renal cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44655,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2599,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7384,"{""doseUnit"": ""MG/KG"", ""route"": ""Oral"", ""doseAmount"": ""0.025"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44656,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2600,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Crohn's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44657,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2603,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44658,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2604,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44659,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2605,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44660,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2605,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Chronic graft versus host disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44661,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2606,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8729,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44662,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2607,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44663,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2608,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.081"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44664,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2611,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44665,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2612,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44666,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2613,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""176"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44667,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2613,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1612.5"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2613,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""108"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44669,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2613,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7279,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44670,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2617,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44671,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2623,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9156,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44672,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2623,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9157,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Colorectal cancer metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44673,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2626,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44674,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2627,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44675,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2628,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44676,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2629,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""55"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44677,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2630,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9158,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""6"", ""indication"": ""Ovarian clear cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44678,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2631,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8240,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44679,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2632,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.036"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44680,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2635,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8194,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44681,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2636,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9159,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44682,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2637,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44683,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2639,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44684,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2640,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7899,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""360"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44685,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2641,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Crohn's disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44686,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2645,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8551,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""700"", ""indication"": ""COVID-19"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44687,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2649,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44688,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2651,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Bone neoplasm"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44689,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2652,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7437,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44690,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2653,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44691,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2654,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8099,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44692,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2655,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8099,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44693,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2655,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44694,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2657,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44695,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2657,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44696,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2658,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""696"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44697,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2658,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44698,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2659,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2.4"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44699,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2660,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""580"", ""indication"": ""Marginal zone lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44700,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2660,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""47"", ""indication"": ""Marginal zone lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2661,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8928,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""66"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44702,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2662,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9136,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Non-small cell lung cancer stage IV"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44703,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2664,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8544,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44704,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2664,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44705,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2667,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8705,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""560"", ""indication"": ""B-cell lymphoma refractory"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44706,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2667,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""B-cell lymphoma refractory"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44707,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2667,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""B-cell lymphoma refractory"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44708,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2667,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8876,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""B-cell lymphoma refractory"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44709,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44710,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9165,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""800"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44711,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2669,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9168,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44712,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2669,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8671,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44713,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2670,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.039"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44714,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2675,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""500"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44715,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2675,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44716,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2677,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Hereditary angioedema"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44717,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2677,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7719,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44718,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2677,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7882,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""22""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44719,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2678,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Contraception"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44720,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2679,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""6000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44721,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2682,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44722,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2683,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8541,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44723,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2684,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44724,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2685,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8670,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44725,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2685,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7435,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""480"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44726,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2685,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8375,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44727,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2686,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44728,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2686,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44729,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2687,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1335"", ""indication"": ""Endometrial cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44730,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2690,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8085,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44731,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2690,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9172,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1850"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44732,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2690,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8903,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""231"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44733,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2693,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9158,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""6"", ""indication"": ""Endometrial cancer stage IV"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44734,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2694,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7235,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.625"", ""indication"": ""Menopause"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44735,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2696,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2"", ""indication"": ""Diabetes mellitus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44736,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2697,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44737,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2698,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44738,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""207"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44739,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""700"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44740,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""53"", ""indication"": ""Unknown"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44741,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7352,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.1"", ""indication"": ""Unknown"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44742,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""264"", ""indication"": ""Unknown"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44743,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1990"", ""indication"": ""Unknown"", ""drugSequence"": ""17""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44744,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""110"", ""indication"": ""Unknown"", ""drugSequence"": ""20""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44745,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2703,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""43"", ""indication"": ""Bile duct cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44746,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2703,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7473,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1710"", ""indication"": ""Bile duct cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44747,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2704,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44748,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2710,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7307,"{""doseUnit"": ""UG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Hyperparathyroidism secondary"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44749,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2713,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9174,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1500"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44750,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2716,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""375"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44751,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2716,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7473,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44752,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2716,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44753,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2716,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""75"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44754,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2717,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44755,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2720,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7681,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Relapsing-remitting multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44756,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2721,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7520,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""150"", ""indication"": ""Triple positive breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44757,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2721,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7735,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Triple positive breast cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44758,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2724,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44759,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2725,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44760,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2727,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8399,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""1400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44761,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2727,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7944,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44762,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2728,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8565,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44763,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2729,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2731,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44765,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2731,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44766,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2731,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44767,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2732,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8509,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44768,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2734,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7460,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44769,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2736,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44770,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2737,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8776,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44771,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2739,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44772,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2740,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2745,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7268,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""80"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44774,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2746,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8509,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""45"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44775,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2746,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8241,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""45"", ""indication"": ""Hairy cell leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44776,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2747,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44777,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2750,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Breast neoplasm"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44778,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2752,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44779,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2755,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44780,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2756,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8451,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.7"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44781,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2757,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44782,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2761,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44783,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2761,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8042,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""36"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44784,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2762,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7918,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44785,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2765,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Ovarian cancer recurrent"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44786,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2765,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""840"", ""indication"": ""Ovarian cancer recurrent"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44787,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2766,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8671,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44788,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2770,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8735,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44789,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""80"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44790,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2774,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.093"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2777,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44792,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2778,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""1600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44793,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2781,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44794,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2783,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8848,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""720"", ""indication"": ""Non-small cell lung cancer stage IV"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44795,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2783,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9136,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""K-ras gene mutation"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44796,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2784,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44797,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2785,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8705,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44798,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2786,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8848,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""480"", ""indication"": ""K-ras gene mutation"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44799,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2790,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8901,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8901,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44801,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2792,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8901,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44802,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2793,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8901,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44803,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2794,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8901,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44804,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2795,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44805,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2796,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8005,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""80"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44806,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2797,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44807,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2797,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8364,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44808,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2798,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7965,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""45"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44809,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2805,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7862,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44810,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2809,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8321,"{""doseUnit"": ""IU"", ""route"": ""Subcutaneous"", ""doseAmount"": ""6000"", ""indication"": ""Prophylaxis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44811,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2814,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7901,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Still's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44812,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2815,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""114.75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44813,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2815,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""76.5"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44814,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2818,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8817,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44815,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2818,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7233,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Anaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44816,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2819,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.117"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44817,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2820,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8670,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44818,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2822,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2"", ""indication"": ""Type 2 diabetes mellitus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44819,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2823,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44820,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9198,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Depression"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44821,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2825,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1800"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44822,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2825,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44823,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2826,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2827,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8004,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""84"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44825,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2829,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8201,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""61"", ""indication"": ""Amyloidosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44826,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2833,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Chronic graft versus host disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44827,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2835,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""MG"", ""route"": ""Subdermal"", ""doseAmount"": ""68"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44828,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2836,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8249,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Asthma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44829,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2837,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44830,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2838,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44831,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2843,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9208,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Ovarian cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44832,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2844,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44833,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2845,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44834,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7920,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44835,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1800"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44836,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44837,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.45"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44838,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2858,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8544,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Drug withdrawal syndrome"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44839,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2858,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9219,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Drug withdrawal syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44840,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2858,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Drug use disorder"", ""drugSequence"": ""47""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44841,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2858,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9220,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.18"", ""indication"": ""Unknown"", ""drugSequence"": ""49""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44842,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2859,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8399,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""1600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44843,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2860,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44844,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2860,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44845,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2864,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9226,"{""doseUnit"": ""IU"", ""route"": ""Oral"", ""doseAmount"": ""36000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44846,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2866,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7997,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44847,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8548,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44848,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Glioblastoma multiforme"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44849,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8997,"{""doseUnit"": ""PCT"", ""route"": ""Intravenous bolus"", ""doseAmount"": ""10"", ""indication"": ""Hypoglycaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44850,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2870,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44851,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2875,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.076"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44852,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2877,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8019,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""250"", ""indication"": ""Supplementation therapy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44853,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2879,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2879,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8852,"{""doseUnit"": ""UG"", ""route"": ""Intramuscular"", ""doseAmount"": ""73826"", ""indication"": ""Skin cancer"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44855,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""560"", ""indication"": ""Central nervous system lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44856,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2882,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44857,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2883,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8551,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""700"", ""indication"": ""COVID-19"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44858,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2884,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Hereditary angioedema"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44859,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2885,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44860,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2886,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.05"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44861,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44862,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2890,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8174,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44863,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2892,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44864,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2897,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9110,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""500"", ""indication"": ""K-ras gene mutation"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44865,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2900,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.028"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44866,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2904,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7683,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""16"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2904,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7188,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1.3"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44868,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2904,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2906,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7965,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""90"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44870,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2907,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7327,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Hypersensitivity"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44871,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2909,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9238,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Ovarian cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44872,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2911,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7411,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Psoriasis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44873,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2912,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44874,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2913,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44875,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2914,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44876,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7860,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""14"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44877,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Non-small cell lung cancer metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44878,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2917,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""85"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44879,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2917,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7435,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""138"", ""indication"": ""Osteosarcoma metastatic"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2919,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8670,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44881,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2920,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9241,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Bladder cancer"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44882,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2920,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""144.9"", ""indication"": ""Bladder cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44883,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2920,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8185,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2068"", ""indication"": ""Bladder cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44884,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2921,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44885,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2922,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5.1"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44886,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2924,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1200"", ""indication"": ""Small cell lung cancer extensive stage"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44887,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2924,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7539,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""448"", ""indication"": ""Small cell lung cancer extensive stage"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2924,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""158"", ""indication"": ""Small cell lung cancer extensive stage"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2927,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8812,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44890,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2927,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8813,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Hormone receptor positive HER2 negative breast cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44891,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7335,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Cerebrovascular accident prophylaxis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44892,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2929,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1000"", ""indication"": ""Follicular lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44893,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2934,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44894,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2936,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.09"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44895,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2939,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44896,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2939,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8220,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Crohn's disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44897,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2941,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""240"", ""indication"": ""Cholangiocarcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44898,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2942,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.035"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44899,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2943,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""184"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44900,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2943,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7991,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""9250"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44901,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2943,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""700"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44902,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2943,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8650,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""9300"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44903,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2944,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8189,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""140"", ""indication"": ""Hyperlipidaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44904,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2946,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44905,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2947,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7502,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44906,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2947,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""840"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44907,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2948,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44908,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2949,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.082"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44909,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2950,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8335,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""0.5"", ""indication"": ""Cardiac failure congestive"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44910,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2954,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2.4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44911,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2955,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44912,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2956,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44913,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2957,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8224,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44914,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2957,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Endometriosis"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2958,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8222,"{""doseUnit"": ""IU"", ""route"": ""Unknown"", ""doseAmount"": ""2500"", ""indication"": ""Angioedema"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44916,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2960,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Contraception"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44917,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2961,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Unknown"", ""doseAmount"": ""0.2"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44918,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2962,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7474,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""750"", ""indication"": ""Urinary tract infection"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44919,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2963,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""K-ras gene mutation"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44920,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2964,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""950"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44921,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2965,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.106"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44922,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2966,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44923,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2967,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.25"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44924,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2968,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44925,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2969,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44926,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2970,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8725,"{""doseUnit"": ""UG"", ""route"": ""Respiratory (inhalation)"", ""doseAmount"": ""12"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44927,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2972,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""52.2"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44929,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""522"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44930,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8705,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44931,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""10"", ""indication"": ""Cytokine release syndrome"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44932,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2975,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8975,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""100"", ""indication"": ""Asthma prophylaxis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44933,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2976,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44934,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2977,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9261,"{""doseUnit"": ""MG"", ""route"": ""Sublingual"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44935,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2981,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.03"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44936,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2982,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44937,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2983,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""560"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44938,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2984,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Myelodysplastic syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44939,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2986,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7918,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44940,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2987,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8118,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44941,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2988,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7442,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""800"", ""indication"": ""Endometrial cancer metastatic"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44942,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2989,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44943,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2991,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44944,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2993,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9267,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Off label use"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44945,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2994,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8400,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44946,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2995,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""4.5"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44947,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2996,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44948,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:2997,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9268,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""7.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44949,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3000,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7965,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""90"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44950,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3001,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7401,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""56"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44951,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3001,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7876,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44952,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3004,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.027"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44953,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3005,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44954,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3007,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9268,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""66.8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44955,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3009,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7477,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44956,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3009,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44957,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3012,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8240,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44958,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3013,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7945,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""7"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44959,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8578,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44960,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3015,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""480"", ""indication"": ""Metastatic malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44961,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3021,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8858,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""42"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44962,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3023,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""280"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44963,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3025,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9274,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44964,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3026,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9120,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""56"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44965,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3028,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9275,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""500"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44966,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3030,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44967,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3030,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8671,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44968,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3031,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8838,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""400"", ""indication"": ""Psoriatic arthropathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44969,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3033,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9276,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1800"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44970,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3034,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7401,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44971,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3034,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9277,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44972,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3038,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""280"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44973,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3039,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9279,"{""doseUnit"": ""UG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44974,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3040,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44975,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3043,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8551,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""700"", ""indication"": ""COVID-19"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44976,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3044,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8551,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""700"", ""indication"": ""COVID-19"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44977,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3047,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""192"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44978,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3049,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8812,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44979,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3049,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8813,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Hormone receptor negative HER2 positive breast cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44980,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3051,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44981,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3053,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8610,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""125"", ""indication"": ""Rheumatoid arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44982,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3054,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7553,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44983,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3054,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44984,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3056,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44985,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3058,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9297,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Thrombocytopenia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44986,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3065,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""900"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44987,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3065,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44988,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3066,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44989,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3067,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44990,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3068,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8189,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""140"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44991,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3070,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.056"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44992,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3071,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44993,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3073,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8671,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44994,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3073,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44995,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3075,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44996,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3078,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7539,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""500"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44997,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3078,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""588"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44998,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3078,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7991,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""9800"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:44999,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3078,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""700"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45000,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3080,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Contraception"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45001,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3082,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Contraception"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45002,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3083,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45003,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3086,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45004,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3088,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45005,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3091,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45006,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3092,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""140"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45007,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3093,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Neutropenia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45008,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3095,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45009,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3097,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45010,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3098,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8528,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3.375"", ""indication"": ""Antibiotic prophylaxis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45011,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3100,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Other"", ""doseAmount"": ""0.279"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45012,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3101,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45013,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3102,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""DF"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Oropharyngeal cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45014,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3104,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45015,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3105,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7997,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45016,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3106,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8399,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""1400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45017,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3107,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8419,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45018,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3108,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8681,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.75"", ""indication"": ""Diabetes mellitus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45019,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3112,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3200"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45020,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3114,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45021,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3117,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45022,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3119,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45023,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3119,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45024,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3121,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7818,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1075"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45025,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3121,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8986,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1200"", ""indication"": ""Hepatocellular carcinoma"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45026,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3122,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45027,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3123,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9044,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""193.25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45028,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3128,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Off label use"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45029,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3130,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45030,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3135,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8859,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45031,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3135,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45032,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3135,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""16"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45033,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3137,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9267,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45034,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3138,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7642,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unevaluable event"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45035,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3141,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8901,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Myasthenic syndrome"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45036,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3143,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45037,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3144,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45038,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3146,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""840"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45039,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3146,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7473,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1748"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45040,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3146,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8067,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""210"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45041,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3147,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7997,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45042,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3150,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Rheumatoid arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45043,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3153,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9311,"{""doseUnit"": ""UG"", ""route"": ""Vaginal"", ""doseAmount"": ""4"", ""indication"": ""Atrophic vulvovaginitis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45044,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3154,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""520"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45045,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3154,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7469,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45046,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3155,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7955,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.5"", ""indication"": ""Myoclonus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45047,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3156,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8502,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""549.9"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45048,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3159,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Off label use"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45049,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3160,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45050,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3161,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45051,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7498,"{""doseUnit"": ""UG"", ""route"": ""Buccal"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45052,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Psoriasis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45053,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3174,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.065"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45054,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3175,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45055,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3177,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9316,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.006"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45056,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3178,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5.75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45057,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3179,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.086"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45058,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3180,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.043"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45059,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3183,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""801"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45060,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3184,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9319,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45061,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3184,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8400,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45062,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3185,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45063,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3188,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""138"", ""indication"": ""Follicular lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45064,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3188,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Follicular lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45065,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3189,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.037"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45066,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3198,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""160"", ""indication"": ""Ankylosing spondylitis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45067,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3200,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9320,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Cushing's syndrome"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45068,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3201,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7255,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45069,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3202,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9187,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45070,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3207,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45071,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3211,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""138"", ""indication"": ""Follicular lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45072,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3211,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Follicular lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45073,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3212,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8407,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""380"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45074,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3215,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45075,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9322,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45076,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3219,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""69"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45077,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3219,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""645"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45078,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3221,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9323,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3600"", ""indication"": ""Myasthenia gravis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45079,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3231,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.078"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45080,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3234,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9329,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""882"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45081,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3235,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7498,"{""doseUnit"": ""UG"", ""route"": ""Buccal"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45082,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3236,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45083,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3239,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45084,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3240,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9297,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45085,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3241,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7498,"{""doseUnit"": ""UG"", ""route"": ""Buccal"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45086,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3243,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8801,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""110"", ""indication"": ""Hereditary angioedema"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45087,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3244,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7498,"{""doseUnit"": ""UG"", ""route"": ""Buccal"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45088,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3245,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9336,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""80"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45089,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3249,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""15"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45090,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3251,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8194,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45091,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3253,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8838,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45092,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3254,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45093,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3256,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45094,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3258,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9337,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Acute lymphocytic leukaemia recurrent"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45095,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3258,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9131,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""0.6"", ""indication"": ""Acute lymphocytic leukaemia recurrent"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45096,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3258,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""750"", ""indication"": ""Acute lymphocytic leukaemia recurrent"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45097,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3258,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7246,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Acute lymphocytic leukaemia recurrent"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45098,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3258,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG/M**2"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Acute lymphocytic leukaemia recurrent"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45099,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3259,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45100,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3260,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8660,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45101,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3264,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Colitis ulcerative"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45102,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3266,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""95"", ""indication"": ""Uveal melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45103,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3267,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8042,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""215"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45104,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3268,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45105,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3270,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.06"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45106,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3271,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9134,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""180"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45107,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3272,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.08"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45108,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3274,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45109,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3275,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45110,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3277,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8578,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45111,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3278,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45112,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3281,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7394,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45113,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3282,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Off label use"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45114,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3283,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.8"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45115,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45116,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""55"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45117,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9341,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Chronic graft versus host disease"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45118,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3289,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45119,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3290,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7298,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Axillary pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45120,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3291,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45121,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3292,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45122,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3297,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45123,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3299,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45124,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45125,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3306,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45126,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3307,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45127,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3309,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7853,"{""doseUnit"": ""DF"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2"", ""indication"": ""Dermatitis atopic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45128,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3310,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45129,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""140"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45130,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45131,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3314,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45132,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7832,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""35"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45133,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3316,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45134,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3319,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Myelodysplastic syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45135,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3322,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""K-ras gene mutation"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45136,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3326,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8451,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2.57"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45137,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3327,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""205.2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45138,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3327,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""68.4"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45139,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3327,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""80"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45140,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3327,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9004,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""32"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45141,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3332,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45142,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3337,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45143,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3337,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7195,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""81"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45144,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3341,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.064"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45145,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3345,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.099"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45146,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3346,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.051"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45147,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3346,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7440,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45148,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3348,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45149,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3351,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45150,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3352,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8578,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45151,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3354,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""6000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45152,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3356,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9297,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Liver disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45153,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3358,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45154,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3359,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45155,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3360,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8290,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""140"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45156,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3363,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45157,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3366,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8548,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45158,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3367,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8941,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45159,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3367,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7759,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45160,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3369,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45161,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3370,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Secondary progressive multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3371,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3372,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45164,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45165,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3375,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45166,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3376,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45167,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3380,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8224,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45168,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3380,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45169,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3382,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45170,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3385,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.125"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45171,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3386,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45172,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3388,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45173,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3389,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Prostate cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45174,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3390,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45175,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7977,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""365"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45176,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9358,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5460"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45177,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9359,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""80"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45178,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8399,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45179,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45180,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3400,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9329,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""1064"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45181,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3402,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7553,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""60"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45182,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8034,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""274"", ""indication"": ""Dyskinesia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45183,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7192,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45184,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7696,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""1000"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45185,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7547,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""5000"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45186,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8433,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45187,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3404,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45188,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3405,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45189,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3411,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8004,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""84"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45190,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3414,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45191,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45192,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9165,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""800"", ""indication"": ""Myelodysplastic syndrome"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45193,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3419,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous drip"", ""doseAmount"": ""37.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45194,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""252"", ""indication"": ""Metastatic malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45195,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3423,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45196,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3424,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45197,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3426,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45198,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3429,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45199,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3431,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8964,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45200,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3433,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.375"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45201,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3434,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""12"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45202,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Rheumatoid arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45203,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3438,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45204,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3439,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45205,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3442,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45206,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7383,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6450"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45207,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""291"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45208,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3445,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9136,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""960"", ""indication"": ""K-ras gene mutation"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45209,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3448,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""480"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45210,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3452,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7782,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Anticoagulant therapy"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45211,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3458,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.043"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45212,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3460,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.087"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45213,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3462,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45214,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3463,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45215,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3465,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45216,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3466,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3468,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45218,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3469,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Rheumatoid arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45219,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3470,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.9"", ""indication"": ""Premature baby"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45220,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3471,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""15"", ""indication"": ""Juvenile idiopathic arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45221,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3471,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9369,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""87.5"", ""indication"": ""Juvenile idiopathic arthritis"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45222,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3471,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7413,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45223,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3472,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""389"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45224,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3472,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9370,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1750"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45225,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3473,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""267"", ""indication"": ""Scleroderma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45226,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3474,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8400,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45227,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3475,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.084"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45228,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3478,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7460,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""35"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45229,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3486,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8622,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45230,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3487,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.35"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45231,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3490,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45232,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.054"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45233,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3493,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45234,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3496,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45235,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3498,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45236,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3503,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.067"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45237,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3509,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45238,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3510,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45239,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3511,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45240,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3513,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45241,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3514,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8189,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""140"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45242,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3518,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8725,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""72"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45243,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3519,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.015"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45244,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3520,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45245,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3521,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9374,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""18"", ""indication"": ""Renal cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45246,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3524,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Rheumatoid arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45247,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3525,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8826,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1200"", ""indication"": ""Invasive breast carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45248,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3525,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8827,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""248"", ""indication"": ""Invasive breast carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45249,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3530,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Contraception"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45250,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3531,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9162,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""800"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45251,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3531,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Clear cell renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45252,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3532,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.036"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45253,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3534,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45254,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3535,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45255,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3535,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45256,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3536,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7182,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45257,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3538,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45258,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3542,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Contraception"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45259,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3546,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45260,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3555,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45261,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3559,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45262,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3562,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""1800"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45263,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3565,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45264,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3568,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8312,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Schizophrenia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45265,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastritis"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45266,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3578,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45267,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3579,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45268,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3582,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45269,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3583,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45270,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3589,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45271,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3592,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45272,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3594,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7251,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""52.9"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45273,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3595,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45274,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3596,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9393,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Bladder cancer"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45275,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3596,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8544,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Bladder cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45276,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3596,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""137"", ""indication"": ""Bladder cancer"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45277,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3596,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8185,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1960"", ""indication"": ""Bladder cancer"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45278,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3598,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45279,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3599,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7945,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""12"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45280,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3600,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45281,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3603,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45282,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3603,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45283,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3608,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45284,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3611,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45285,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3613,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.017"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3617,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9394,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45287,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3623,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7997,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3624,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9268,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45289,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3626,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45290,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3628,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45291,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3632,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7177,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""40"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45292,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3632,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7253,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""1200"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45293,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3633,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45294,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3636,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Neoplasm"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45295,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3636,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Neoplasm"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45296,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3637,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8189,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""140"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45297,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3639,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""975"", ""indication"": ""Endometrial cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45298,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3643,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.044"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45299,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3644,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3645,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45301,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3645,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Hyperchlorhydria"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3647,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45303,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3648,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45304,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3649,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45305,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3650,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45306,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3653,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Transitional cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45307,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3654,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45308,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3655,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9174,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1500"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45309,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3658,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45310,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3659,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45311,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3664,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3665,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3666,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45314,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3670,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45316,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3675,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3676,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8812,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45318,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3677,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.375"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45319,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3678,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45320,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3680,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45321,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3681,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45322,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3682,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8847,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2"", ""indication"": ""Type 2 diabetes mellitus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45323,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3684,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8655,"{""doseUnit"": ""ML"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Magnetic resonance imaging"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45324,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3685,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8243,"{""doseUnit"": ""UG"", ""route"": ""Transdermal"", ""doseAmount"": ""37.5"", ""indication"": ""Back pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45325,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3686,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9374,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""18"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45326,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3687,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9399,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""750"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45327,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3688,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7901,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""180"", ""indication"": ""Still's disease"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3688,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9404,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45329,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3688,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7904,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Haemophagocytic lymphohistiocytosis"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45330,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3688,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7433,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1.6"", ""indication"": ""Still's disease"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45331,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3688,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9405,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""70"", ""indication"": ""Still's disease"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45332,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3689,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9406,"{""doseUnit"": ""MG/M**2"", ""route"": ""Unknown"", ""doseAmount"": ""400"", ""indication"": ""Gallbladder cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45333,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3689,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9030,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Gallbladder cancer metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45334,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3692,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45335,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3693,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.05"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45336,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3694,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9406,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""750"", ""indication"": ""Cholangiocarcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45337,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3694,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9030,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""130.892"", ""indication"": ""Cholangiocarcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45338,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3694,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""240"", ""indication"": ""Cholangiocarcinoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45339,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3695,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9030,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""144.179"", ""indication"": ""Colon cancer"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45340,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3696,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45341,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.056"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45342,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3706,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7489,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Diabetes mellitus"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45343,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3706,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7678,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1000"", ""indication"": ""Seizure"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45344,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3706,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7660,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45345,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3706,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9408,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45346,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3708,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8240,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""T-cell prolymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45347,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3710,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8725,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""54"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45348,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3712,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7539,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""566"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45349,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3712,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9410,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""875"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45350,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3714,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45351,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3714,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Abdominal pain upper"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45352,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3718,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.037"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45353,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3720,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45354,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3721,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45355,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3725,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45356,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3726,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45357,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3729,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7951,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""1000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45358,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3729,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9412,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""185"", ""indication"": ""Ewing's sarcoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45359,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3735,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8400,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45360,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3736,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45361,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3737,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8340,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45362,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3738,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8247,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45363,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3739,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""217.8"", ""indication"": ""Glioblastoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45364,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3741,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45365,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3742,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45366,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3742,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Hyperchlorhydria"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45367,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3743,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45368,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3743,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45369,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3744,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7850,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""90"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45370,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3746,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45371,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3747,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45372,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3750,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9421,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1440"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45373,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3751,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.04"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3758,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7883,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45375,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9425,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45376,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3765,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45377,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3767,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8189,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""420"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45378,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3769,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8502,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1.2"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45379,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3769,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9358,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""375"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45380,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3769,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9427,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""6"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45381,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3769,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Hodgkin's disease"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45382,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3770,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45383,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3771,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8850,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Hepatobiliary cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45384,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3771,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8851,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2400"", ""indication"": ""Hepatobiliary cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45385,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3778,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45386,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3780,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45387,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3781,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45388,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3782,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45389,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3785,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45390,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3789,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45391,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Intrathecal"", ""doseAmount"": ""15"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45393,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45395,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45396,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3792,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45397,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3794,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45398,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3795,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""920"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45399,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3795,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9429,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1225"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45400,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3795,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7332,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""12.5"", ""indication"": ""B precursor type acute leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45401,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3797,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45402,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3798,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45404,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3802,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45405,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3804,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45406,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3805,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45407,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3805,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7182,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45408,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3810,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8906,"{""doseUnit"": ""ML"", ""route"": ""Oral"", ""doseAmount"": ""16.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45409,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3813,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9432,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45410,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3815,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45411,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3816,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""700"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45412,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3817,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45413,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3818,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45414,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3821,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45415,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3822,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9434,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Neurofibromatosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3823,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45417,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3825,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3826,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45419,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3829,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45420,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3830,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""1600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3831,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3832,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45423,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3833,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45424,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3834,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9436,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45425,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3835,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45426,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3837,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45427,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3838,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7853,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45428,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3841,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45429,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3842,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45430,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3843,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8383,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""32"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45431,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3844,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8838,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""400"", ""indication"": ""Arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45432,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3845,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9437,"{""doseUnit"": ""UG"", ""route"": ""Urethral"", ""doseAmount"": ""500"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45433,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3848,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45434,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3850,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7456,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""550"", ""indication"": ""Severe myoclonic epilepsy of infancy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45435,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3852,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7899,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45436,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3852,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8776,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Metastatic malignant melanoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8189,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""140"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45438,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3856,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45439,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3857,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Dyspepsia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45440,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3865,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45441,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3870,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.06"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45442,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3872,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7994,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""420"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45443,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3875,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7249,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""120"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45444,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3875,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7248,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Multiple sclerosis"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45445,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3877,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3878,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8827,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3.6"", ""indication"": ""HER2 positive breast cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45447,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8321,"{""doseUnit"": ""IU"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5000"", ""indication"": ""Prophylaxis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45448,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3881,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9341,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Graft versus host disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45449,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3883,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7192,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45450,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3883,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7162,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45451,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3883,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8034,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""274"", ""indication"": ""Dyskinesia"", ""drugSequence"": ""14""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45452,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3884,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.066"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45453,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3885,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7319,"{""doseUnit"": ""IU"", ""route"": ""Subcutaneous"", ""doseAmount"": ""62"", ""indication"": ""Type 2 diabetes mellitus"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45454,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9412,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""136.482"", ""indication"": ""Metastasis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45455,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7696,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""1000"", ""indication"": ""Vitamin B12 deficiency"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45456,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7620,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Diarrhoea"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45457,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7203,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45458,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7270,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45459,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7247,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45460,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7911,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Pain"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45461,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3890,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8686,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Asthma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45462,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3893,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45463,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3899,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45464,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3903,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.07"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45465,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3908,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45466,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3909,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45467,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3910,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Psoriasis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45468,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3912,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45469,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3913,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45470,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9191,"{""doseUnit"": ""DF"", ""route"": ""Respiratory (inhalation)"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45471,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7194,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45472,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7341,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""325"", ""indication"": ""Unknown"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45473,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9446,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""800"", ""indication"": ""Unknown"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45474,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7653,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""13""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45475,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""15""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45476,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3915,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7505,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""17""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45477,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3918,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7365,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary embolism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45478,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3920,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7984,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Hypersensitivity"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45479,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3924,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9319,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45480,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3926,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.068"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45481,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3928,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9451,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45482,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3929,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45483,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3930,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45484,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3934,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1.6"", ""indication"": ""Growth failure"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45485,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3935,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9453,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""76"", ""indication"": ""Parenteral nutrition"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45486,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3936,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45487,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3938,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45488,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3940,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45489,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3941,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7506,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45490,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3942,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.05"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45491,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3944,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Hyperchlorhydria"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45492,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3946,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Gastric pH increased"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45493,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3950,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45494,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3954,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45495,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3956,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8737,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""125"", ""indication"": ""Juvenile idiopathic arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45496,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3957,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9455,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45497,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3958,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45498,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3959,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45499,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3962,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9456,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Attention deficit hyperactivity disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45500,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3965,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45501,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3967,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7955,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45502,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3967,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9170,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1000"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45503,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3979,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""200"", ""indication"": ""Sarcoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45504,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3980,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45505,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3981,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""105"", ""indication"": ""Glioblastoma multiforme"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45506,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3982,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""1400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45507,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3993,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3.25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45508,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3994,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7898,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5.25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45509,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3996,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.111"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45510,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3997,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45511,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3998,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.069"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45512,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:3999,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45513,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4002,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8400,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45514,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4004,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45515,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4005,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45516,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4006,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7173,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1750"", ""indication"": ""Unknown"", ""drugSequence"": ""8""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45517,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4012,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8671,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45518,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4013,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""800"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45519,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4015,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8622,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45520,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4019,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45521,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4025,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7435,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""480"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45522,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4025,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8375,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45523,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4026,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Off label use"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45524,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4027,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Pulmonary hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45525,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4029,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9480,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45526,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4030,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45527,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4032,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8578,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""150"", ""indication"": ""Psoriasis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45528,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4038,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Psoriatic arthropathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45529,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4039,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45530,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4044,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.073"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45531,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4045,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7545,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45532,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4046,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1235"", ""indication"": ""Endometrial cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45533,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4047,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45534,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4049,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""500"", ""indication"": ""Breast cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45535,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4051,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8222,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Immune system disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45536,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4053,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45537,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4057,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45538,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4058,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45539,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4059,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7325,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45540,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4059,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7546,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45541,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4059,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7366,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""11""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45542,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4059,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7371,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""20"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45543,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4059,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7203,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""16""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45544,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4059,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7230,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""21""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45545,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4059,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7552,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""24""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45546,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4059,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7553,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""60"", ""indication"": ""Gastrooesophageal reflux disease"", ""drugSequence"": ""25""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45547,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4060,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.012"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45548,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4062,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Contraception"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45549,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4064,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7862,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45550,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4065,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""0.052"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45551,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4068,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45552,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4069,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45553,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4070,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45554,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4071,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7335,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45555,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4072,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7335,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45556,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4075,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45557,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4076,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Uterine leiomyoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45558,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4078,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9406,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""810"", ""indication"": ""Cholangiocarcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45559,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4078,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9030,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""111.112"", ""indication"": ""Cholangiocarcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45560,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4078,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""240"", ""indication"": ""Cholangiocarcinoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45561,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4079,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45562,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4080,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45563,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4081,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45564,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4082,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9488,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""300"", ""indication"": ""Pancreatic carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45565,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4083,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1680"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45566,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4083,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""375"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45567,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4083,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8185,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""750"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45568,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4083,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""75"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""12""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45569,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4084,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45570,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4086,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7995,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45571,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4089,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45572,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4092,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45573,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4094,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9490,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45574,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4098,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45575,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4100,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45576,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4108,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8838,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45577,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4110,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9406,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Neuroendocrine carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45578,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4110,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9030,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Neuroendocrine carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45579,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4112,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7334,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""70"", ""indication"": ""Off label use"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45580,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4113,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Off label use"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45581,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4114,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45582,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4120,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""1200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45583,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4121,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""280"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45584,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4122,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8766,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.92"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45585,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4124,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Plasma cell myeloma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45586,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4126,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7278,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45587,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4128,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7685,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45588,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4131,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7163,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45589,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4132,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7438,"{""doseUnit"": ""UG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.046"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45590,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4133,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45591,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4134,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45592,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4136,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""1200"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45593,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4137,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7392,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45594,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4139,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9004,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.5"", ""indication"": ""Lung transplant"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45595,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4139,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7321,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1000"", ""indication"": ""Lung transplant"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45596,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4140,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9495,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Lung cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45597,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4141,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""138"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45598,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4142,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45599,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4143,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9496,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""675"", ""indication"": ""Bipolar disorder"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45600,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4148,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45601,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4151,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8225,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Endometriosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45602,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4156,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8561,"{""doseUnit"": ""MG"", ""route"": ""Transplacental"", ""doseAmount"": ""50"", ""indication"": ""HIV infection"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45603,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4159,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9173,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2"", ""indication"": ""Type 2 diabetes mellitus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45604,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4161,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Acute myeloid leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45605,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4162,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9501,"{""doseUnit"": ""Dental"", ""route"": ""000 epinephrine"", ""doseAmount"": ""EPINEPHRINE BITARTRATE\\LIDOCAINE HYDROCHLORIDE"", ""indication"": ""3"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45606,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4163,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9019,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""3"", ""indication"": ""Diabetes mellitus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45607,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4164,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""591"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45608,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4164,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Chronic lymphocytic leukaemia"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45609,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4165,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""3"", ""indication"": ""Bone density abnormal"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45610,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4168,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8766,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.92"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45611,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4169,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7283,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45612,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4172,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8099,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45613,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4172,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Colorectal cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45614,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4173,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7613,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""480"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45615,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4174,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2.5"", ""indication"": ""Short-bowel syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45616,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4175,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8188,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""160"", ""indication"": ""Prostate cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45617,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4176,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7354,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45618,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4176,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""35"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45619,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4176,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7353,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""85"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45620,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4176,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7781,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""Philadelphia positive acute lymphocytic leukaemia"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45621,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4177,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45622,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4179,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8762,"{""doseUnit"": ""DF"", ""route"": ""Subdermal"", ""doseAmount"": ""1"", ""indication"": ""Contraception"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45623,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4180,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45624,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4182,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""1200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45625,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4183,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8478,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45626,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4183,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7435,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""240"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45627,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4184,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8223,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Nephroblastoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45628,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4186,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45629,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4191,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9061,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45630,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4192,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7356,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Urinary incontinence"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45631,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4193,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Spinal osteoarthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45632,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4195,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45633,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4196,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7687,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""15"", ""indication"": ""Gigantism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45634,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4197,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45635,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4198,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8506,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""0.33"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45636,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4200,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Osteoarthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45637,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4201,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9095,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45638,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4202,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45639,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4203,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45640,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4204,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""3.25"", ""indication"": ""Cataplexy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45641,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4205,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45642,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4206,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Osteoarthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45643,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4207,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45644,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4208,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""500"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45645,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4210,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7315,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45646,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4212,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7305,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Peripheral nervous system function test abnormal"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45647,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4213,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9527,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""250"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45648,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4214,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Limb discomfort"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45649,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4215,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Fibromyalgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45650,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4216,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45651,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4217,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""22"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45652,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4218,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Diabetic neuropathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45653,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4219,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""150"", ""indication"": ""Burning sensation"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45654,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4220,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7160,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""7.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45655,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4221,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7537,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""15"", ""indication"": ""Hepatocellular carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45656,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4221,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9533,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Pain"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45657,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4222,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Radiculopathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45658,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4223,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7206,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45659,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4224,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Osteoarthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45660,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4226,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""125"", ""indication"": ""Breast cancer female"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45661,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4227,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45662,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4228,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45663,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4228,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7486,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2.5"", ""indication"": ""Breast cancer metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45664,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4229,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""125"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45665,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4230,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45666,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4232,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Post herpetic neuralgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45667,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4233,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7525,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""4"", ""indication"": ""Relapsing multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45668,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4234,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7452,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""8.4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45669,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4237,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45670,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4238,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45671,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4239,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7478,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45672,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4240,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45673,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4241,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45674,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4242,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45675,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4244,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Pain in extremity"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45676,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4246,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45677,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4247,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7874,"{""doseUnit"": ""IU"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""3000"", ""indication"": ""Factor VIII deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45678,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4248,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45679,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4249,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""DF"", ""route"": ""Unknown"", ""doseAmount"": ""3"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45680,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4251,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7191,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""4.5"", ""indication"": ""Cataplexy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45681,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4252,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.8"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45682,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4253,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45683,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4255,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45684,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4256,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Sciatica"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45685,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4257,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""600"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45686,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4259,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Polyneuropathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45687,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4260,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Neuropathy peripheral"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45688,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4260,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7505,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Back pain"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45689,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4261,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7437,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45690,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4262,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7681,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""14"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45691,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4263,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""840"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45692,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4263,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7473,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45693,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4263,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8067,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""125"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45694,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4264,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""743"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45695,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4264,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""99"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45696,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4264,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1486"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45697,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4264,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45698,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4266,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Neuralgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45699,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4267,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""700"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45700,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4268,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7249,"{""doseUnit"": ""MG"", ""route"": ""Other"", ""doseAmount"": ""240"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45701,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4269,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Fibromyalgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45702,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4271,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""840"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45703,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4271,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8067,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""125"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45704,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4271,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7473,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1000"", ""indication"": ""Pancreatic carcinoma metastatic"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45705,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4273,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7452,"{""doseUnit"": ""G"", ""route"": ""Oral"", ""doseAmount"": ""8.4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45706,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4275,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7384,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45707,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4276,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""225"", ""indication"": ""Systemic lupus erythematosus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45708,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4277,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Pain in extremity"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45709,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4278,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Neuralgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45710,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4280,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7245,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45711,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4280,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100.6"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45712,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4280,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1508"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45713,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4280,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45714,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4281,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""76"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45715,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4281,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1140"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45716,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4281,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45717,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4282,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7874,"{""doseUnit"": ""IU"", ""route"": ""Intravenous drip"", ""doseAmount"": ""5600"", ""indication"": ""Factor VIII deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45718,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4283,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Polyneuropathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45719,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4284,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7490,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Menopausal symptoms"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45720,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4285,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""574"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45721,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4285,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""77"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45722,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4285,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1150"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45723,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4285,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45724,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4286,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7235,"{""doseUnit"": ""G"", ""route"": ""Vaginal"", ""doseAmount"": ""0.5"", ""indication"": ""Vulval operation"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45725,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4287,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Fibromyalgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45726,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4288,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45727,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4289,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7496,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""600"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45728,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4290,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Sciatic nerve neuropathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45729,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4291,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7860,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45730,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4291,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""200"", ""indication"": ""Hepatocellular carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45731,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4292,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""52"", ""indication"": ""Chemotherapy"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45732,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4293,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Narcolepsy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45733,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4294,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8091,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45734,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4295,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Arthritis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45735,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4296,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45736,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4297,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45737,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4298,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45738,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4298,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7502,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""60"", ""indication"": ""Ovarian cancer recurrent"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45739,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4298,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""840"", ""indication"": ""Ovarian cancer recurrent"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45740,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4299,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7490,"{""doseUnit"": ""DF"", ""route"": ""Oral"", ""doseAmount"": ""1"", ""indication"": ""Back pain"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45741,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4300,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Diabetic neuropathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45742,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4301,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Pruritus"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45743,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4302,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7338,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""5"", ""indication"": ""Dermatitis atopic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45744,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4303,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45745,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4304,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""626"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45746,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4304,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7244,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""83.5"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45747,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4304,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7237,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1253"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45748,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4304,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7171,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Diffuse large B-cell lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45749,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4305,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7414,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""80"", ""indication"": ""Dyslipidaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45750,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4306,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45751,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4307,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""300"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45752,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4308,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7961,"{""doseUnit"": ""UG"", ""route"": ""Other"", ""doseAmount"": ""100"", ""indication"": ""Hypoparathyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45753,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4309,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45754,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4310,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45755,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4311,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9168,"{""doseUnit"": ""DF"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45756,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7383,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""300"", ""indication"": ""Hairy cell leukaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45757,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4312,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7384,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Neoplasm malignant"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45758,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4313,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8151,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1500"", ""indication"": ""Focal dyscognitive seizures"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45759,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4314,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Congenital hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45760,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4315,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7715,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""50"", ""indication"": ""Lung disorder"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45761,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4316,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""45"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45762,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4317,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Polyneuropathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45763,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4318,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45764,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4319,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45765,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4322,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""140"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45766,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4323,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""35"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45767,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4324,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45768,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4325,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""42.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45769,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4326,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7361,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""11"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45770,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4327,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""MG/KG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""500"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45771,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7378,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45772,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9600,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45773,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4328,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9601,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""372"", ""indication"": ""Non-small cell lung cancer"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45774,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4329,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45775,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4330,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45776,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4331,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Neuralgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45777,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4332,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8058,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""4476"", ""indication"": ""Alpha-1 antitrypsin deficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45778,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4333,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45779,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4334,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45780,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4336,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8468,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""90"", ""indication"": ""Lung adenocarcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45781,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4337,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45782,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4338,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7983,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""4"", ""indication"": ""Renal transplant"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45783,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4339,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7178,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""50"", ""indication"": ""Post herpetic neuralgia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45784,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4340,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""21"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45785,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4341,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7536,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1200"", ""indication"": ""Hepatocellular carcinoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45786,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4343,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8098,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Uterine prolapse"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45787,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4344,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45788,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4345,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7996,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45789,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4346,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""6"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45790,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4347,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""33"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45791,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4348,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45792,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4350,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""50"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45793,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4352,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45794,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4353,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""45"", ""indication"": ""Myasthenia gravis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45795,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4354,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""35"", ""indication"": ""Hypogammaglobulinaemia"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45796,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4355,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7442,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""658"", ""indication"": ""Oropharyngeal cancer"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45797,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4355,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9603,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Oropharyngeal cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45798,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4355,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7300,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Pain"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45799,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4356,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""22.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45800,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4357,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""8"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45801,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4358,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""18"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45802,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4359,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""60"", ""indication"": ""Primary immunodeficiency syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45803,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4360,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""3.2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45804,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4361,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45805,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4362,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8093,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45806,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4363,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7288,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45807,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4364,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45808,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4365,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""60"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45809,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4366,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""10"", ""indication"": ""Sjogren's syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45810,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4367,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45811,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4368,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8577,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45812,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4369,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7904,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45813,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4371,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""35"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45814,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4372,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8040,"{""doseUnit"": ""UG"", ""route"": ""Unknown"", ""doseAmount"": ""30"", ""indication"": ""Multiple sclerosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45815,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4373,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""80"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45816,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4374,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45817,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4375,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45818,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4376,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8176,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""140"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45819,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4377,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9031,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""10""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45820,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4379,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45821,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4380,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""280"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45822,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4383,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45823,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4384,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7850,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""90"", ""indication"": ""Adenocarcinoma metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45824,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4385,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7961,"{""doseUnit"": ""UG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""50"", ""indication"": ""Hypoparathyroidism"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45825,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4386,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Combined immunodeficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45826,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4388,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45827,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4389,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8735,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""100"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45828,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4390,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45829,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4391,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8340,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45830,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7978,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""85"", ""indication"": ""Colon cancer"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45831,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8294,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Colon cancer"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45832,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4392,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8702,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""400"", ""indication"": ""Colon cancer"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45833,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4394,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""16"", ""indication"": ""Primary immunodeficiency syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45834,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4396,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7662,"{""doseUnit"": ""MG/KG"", ""route"": ""Unknown"", ""doseAmount"": ""1"", ""indication"": ""Cervix carcinoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45835,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4397,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45836,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4399,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7254,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.261"", ""indication"": ""Diarrhoea"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45837,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4400,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""6"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45838,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4401,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""42"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45839,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4403,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45840,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4404,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""20"", ""indication"": ""Osteoporosis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45841,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4405,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""35"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45842,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4406,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""20"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45843,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4407,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8735,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45844,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4408,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7688,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""160"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45845,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4409,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7979,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""47.5"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45846,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4410,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8419,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""2580"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45847,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4411,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""400"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45848,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4411,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9632,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""25"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45849,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4412,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""10"", ""indication"": ""Psoriatic arthropathy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45850,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4413,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""43"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45851,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4414,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7280,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""125"", ""indication"": ""Bone cancer metastatic"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45852,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4415,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8735,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45853,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""204"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""1""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45854,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""800"", ""indication"": ""Non-Hodgkin's lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45855,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4416,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""8.2"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45856,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4418,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8419,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""1800"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45857,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4419,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""70"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45858,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4420,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7940,"{""doseUnit"": ""MG"", ""route"": ""Intramuscular"", ""doseAmount"": ""800"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45859,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4420,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7443,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""204"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45860,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4420,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7469,"{""doseUnit"": ""MG/KG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""8"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45861,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4420,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7333,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""8.2"", ""indication"": ""B-cell lymphoma"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45862,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4421,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7632,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""0.4"", ""indication"": ""Secondary adrenocortical insufficiency"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45863,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7718,"{""doseUnit"": ""ML"", ""route"": ""Subcutaneous"", ""doseAmount"": ""2"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45864,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4422,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7882,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Hereditary angioedema"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45865,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4424,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""30"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45866,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4426,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8350,"{""doseUnit"": ""MG/M**2"", ""route"": ""Subcutaneous"", ""doseAmount"": ""75"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45867,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4426,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7993,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Myelodysplastic syndrome"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45868,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4427,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""200"", ""indication"": ""Colorectal cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45869,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4428,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Unknown"", ""doseAmount"": ""2"", ""indication"": ""Primary immunodeficiency syndrome"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45870,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4430,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45871,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4431,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8531,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""4"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45872,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4431,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Renal cell carcinoma"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45873,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4432,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7982,"{""doseUnit"": ""G"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""40"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45874,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4433,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous drip"", ""doseAmount"": ""200"", ""indication"": ""Squamous cell carcinoma of head and neck"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45875,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4434,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8321,"{""doseUnit"": ""IU"", ""route"": ""Subcutaneous"", ""doseAmount"": ""5000"", ""indication"": ""Prophylaxis"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45876,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4435,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7383,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""150"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45877,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4435,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8569,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""2"", ""indication"": ""Anaplastic thyroid cancer"", ""drugSequence"": ""38""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45878,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4436,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7383,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""25"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45879,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4436,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7759,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""0.375"", ""indication"": ""Astrocytoma"", ""drugSequence"": ""9""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45880,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8254,"{""doseUnit"": ""MG"", ""route"": ""Subcutaneous"", ""doseAmount"": ""1"", ""indication"": ""Immune enhancement therapy"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45881,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7448,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""100"", ""indication"": ""Unknown"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45882,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9650,"{""doseUnit"": ""ML"", ""route"": ""Intramuscular"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""4""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45883,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9651,"{""doseUnit"": ""ML"", ""route"": ""Intramuscular"", ""doseAmount"": ""0.5"", ""indication"": ""Unknown"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45884,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4437,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9652,"{""doseUnit"": ""ML"", ""route"": ""Intramuscular"", ""doseAmount"": ""1"", ""indication"": ""Unknown"", ""drugSequence"": ""6""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45885,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4438,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7790,"{""doseUnit"": ""G"", ""route"": ""Subcutaneous"", ""doseAmount"": ""12"", ""indication"": ""Immunodeficiency common variable"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45886,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4440,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""1000"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45887,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4440,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG/M**2"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""175"", ""indication"": ""Endometrial cancer"", ""drugSequence"": ""5""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45888,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4441,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7416,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""200"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45889,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4441,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8204,"{""doseUnit"": ""MG"", ""route"": ""Unknown"", ""doseAmount"": ""500"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45890,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4441,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7538,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""270"", ""indication"": ""Ovarian cancer"", ""drugSequence"": ""7""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45891,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4442,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:9654,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Malignant melanoma"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45892,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4443,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7176,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""15"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45893,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4445,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8014,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""140"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45894,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4446,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:7861,"{""doseUnit"": ""MG"", ""route"": ""Intravenous (not otherwise specified)"", ""doseAmount"": ""200"", ""indication"": ""Bile duct cancer"", ""drugSequence"": ""3""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45895,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4447,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8775,"{""doseUnit"": ""UG"", ""route"": ""Oral"", ""doseAmount"": ""400"", ""indication"": ""Unknown"", ""drugSequence"": ""2""}"
5:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:45896,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:4447,4:a4ea6acb-b5fc-4a33-a21a-e4f10b877c39:8671,"{""doseUnit"": ""MG"", ""route"": ""Oral"", ""doseAmount"": ""10"", ""indication"": ""Pulmonary arterial hypertension"", ""drugSequence"": ""4""}"
